Antibiotikaforbrugsmønstre på udvalgte hospitalsafdelinger ... · Antibiotikaforbrugsmønstre på udvalgte hospitalsafdelinger i Region Hovedstaden Task Force Forebyggelse af Hospitalsinfektioner

Antibiotikaforbrugsmønstre på udvalgtehospitalsafdelinger i Region Hovedstaden

Task Force Forebyggelse af Hospitalsinfektioner i Region Hovedstaden2016-05-23 (udkast)

Indhold

Indledning 6

Bispebjerg og Frederiksberg Hospitaler 7

- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

Abdominalcenter K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

Akutmodtagelsen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

Anæstesiafdeling Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15

Dermato-Venerologisk Afdeling og Videncenter for Sårheling . . . . . . . . . . . . . . . . . . . . 17

Endokrinologisk Afdeling I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19

Geriatrisk Afdeling G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21

Hjerteafdeling Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23

Lungemedicinsk Afdeling L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25

Medicinsk Afdeling C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

Neurologisk Afdeling N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29

Ortopædkirurgisk Afdeling M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31

Ortopædkirurgisk Afdeling O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33

Palliativ Medicinsk Afdeling P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35

Reumatologisk Afdeling H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37

Urologisk Afdeling U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39

Bornholms Hospital 41

Akutmodtagelse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43

Apoteket/Nødberedskab . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45

Dialyseafsnit F2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47

Endagsafsnit A.O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49

Hjerteafsnit F0-1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51

Hjerteafsnit F0-2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53

Intensiv . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55

Kirurgisk afdeling A.1.1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57

Kirurgisk ambulatorium D.0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59

Medicinsk ambulatorium A.O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61

MKO amb/CYTO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63

1

MKO seng . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65

Neurologisk og Børneafs F1-1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67

Neurologisk og Børneafs F1-2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69

OP/Anæstesi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71

Herlev og Gentofte Hospital 73

- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75

Akutmodtagelsen A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77

Anæstesiologisk I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79

Anæstesiologisk Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81

Brystkirurgisk F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83

Børneafdeling E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85

Gastroenheden D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

Gyn.-Obs G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89

Hjertemedicinsk S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91

Hud- Og Allergiafdeling U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93

Hæmatologisk L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95

Lungemedicinsk Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97

Medicinsk Afdeling O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Medicinsk C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101

Nefrologisk B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103

Neurologisk N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105

Onkologisk R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107

Ortopædkirurgisk T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109

Plastikkirurgisk V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111

Urologisk H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113

Amager og Hvidovre Hospital 115

Akutklinik, kir skadeafs team3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117

Akutklinik, obs afs modtagelse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119

Akutklinik, observationsafs + lungemed sengeafs . . . . . . . . . . . . . . . . . . . . . . . . . . 121

Akutklinik, Skader . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123

Akutklinikken afs MGSAKUT 40 GLO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125

C Kardiologisk Sengeafsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127

Endo og lunge sengeafs. MG33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129

Geriatrisk sengeafsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131

HH Akutmodtagelsen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133

HH Barsel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135

HH Børneafd . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137

HH Børneambulatorium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139

2

HH Børnedagafsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141

HH Børnemodtagelsen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143

HH Dagkirurgisk afdeling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145

HH Dagkirurgisk operation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147

HH Endokrinologisk amb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149

HH Fertilitetsklinik . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151

HH Fødeafsnit, voksne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153

HH Gastroentero Endoskopiafs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155

HH Gynækologi, cop-varer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157

HH Gynækologisk amb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159

HH Gynækologisk sengeafs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161

HH Gynækologisk/Obstetrisk afd . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163

HH Hjerte-og lungemed sengeafd . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165

HH Hjerteinsufficiensklinik . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167

HH Infektionsmedicin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169

HH Infektionsmedicinsk amb DOBBELTKONTROL Hele kassser . . . . . . . . . . . . . . . . . 171

HH Intensiv terapi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173

HH Intern opvågning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175

HH Kardiologi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177

HH Kir Gast. 5-døgnsafs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179

HH Kir gastro. cop-varer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181

HH Kir gastroent. sengeafs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183

HH Klinisk mikrobiologi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185

HH Lungemedicinsk dagafsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187

HH Neonatalafsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189

HH Obstetrik Barsel 412 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191

HH Obstetrik svangre sengeafs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193

HH Ortopædkirurgi 312 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195

HH Ortopædkirurgi 315 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197

HH Ortopædkirurgi amb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 199

HH Ortopædkirurgi, cop-varer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201

HH Palliativ Enhed amb/seng . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203

Kardiologisk sengeafs MG31 GLO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205

Kardiologisk Sengeafsnit C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207

Lungemedicinsk afsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 209

Lungemedicinsk Sengeafsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 211

Med. geri. sengeafs. MG42 GLO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 213

Med. kadio. sengeafs. MG32 GLO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215

Medicinsk dagafsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217

3

Medicinsk modtage afs MGIMOD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219

Observationsafsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221

Observationsafsnit, modtagelse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223

Nordsjællands Hospital 225

Akut gyn/Bækkenbundsklinikken . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227

Akut modt for gravide 0131 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 229

Akutafdelingen BASE 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231



Akutklinik skadestueafs FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237

Akutklinik, sengeafs FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 239

Akutklinik, sygepl-afs SH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241

Anæstesi/OP afs 0133 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243

Anæstesiologisk afd HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245

Barselsafs 1 sengeafs 1543 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 247

Barselsafsnit 2 senge. G 0142 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 249

Børne og unge akutmod 1521 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251

Børne og unge sengeafs 0632 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 253



Dag. kir. afs. 0162 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259

Dagkirurgisk afs 0153 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 261

Gyn amb-afs G 0211 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 263

Gyn sengeafs G 0121 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265

HI Onkologisk senge. E 0861 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 267

Håndkirurgisk klinik 0823 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269

Infektiomed sengafs 0651 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271

Infektiomed sengafs 0651Nord . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273

Intensiv afd 0531 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275

Intermediært sengeafs 0633 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 277

Kard-Endo senge afs. B1 FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 279

Kard-Endo senge afs. B2 FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 281

Kardiologi amb afs 0841 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 283

KardNefroEndo sengeafs 0641 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 285

KardNefroEndo sengeafs 0842 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 287

Kir sengeafs 0141 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 289

Kir sengeafs B5 FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 291

Kir sengeafs B6 FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 293

Kir sengeafs K 0151 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295

4

Kir sengeafs K 0161 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 297

Kir. endoskopiafs. FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 299

Lunge & inf.med. amb 0621 Lægegangen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 301

Lungemed sengeafs 0655 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303

Lungemed. Sengeafd. B7 FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 305

Lungemed. Sengeafd. B8 FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 307

Nefrologisk amb-afs 0732 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 309

Nefrologisk HD-amb 0851 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 311

Nefrologisk HD amb-afs 0921 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 313

Neurologisk afd 0671 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315

Neurologisk sengeafs 0871 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 317

Neurorehab.sengeafs. A1 FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 319

Neurorehab.sengeafs. A3 FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 321

Onkologisk amb E 0663 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 323

Opvågnings afsnit 0132 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 325

Ortkir amb-afs afs 0731 Hi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 327

Ortkir sengeafs O 0152 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 329

Ortkir sengeafs O 1551 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 331

Ortkir sengeafsnit 0661 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 333

Palliativ sengafs A7A8 FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 335

SimNord indgang 51A, plan 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 337

Øre-næse-hals amb C 0832 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 339

Øre-næse-hals OP afs C 0822 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 341

Øre-næse-hals sengeafs 0631 HI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 343

Rigshospitalet og Glostrup Hospital 345- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 347

BørneUngeKlinikken . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 349

Hjerte-medicinsk Klinik B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 351

Hæmatologisk Klinik 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 353



Intensiv Terapi Afsnit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 359

Kirurgisk Gastroenterologisk Klinik C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 361

Nefrologisk Klinik . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 363

Neuroanæstesiologisk Klinik . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 365

Neurokirurgisk klinik . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 367

Onkologisk klinik . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 369

Ortopædkirurgisk klinik . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 371

Thorax-kirurgisk Klinik RT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 373

Thoraxanæstesiologisk Klinik . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 375

5

Indledning

Diagrammerne på de følgende sider viser antibiotikaforbruget på udvalgte hospitalsafdelinger. Forbrugeter opgjort i definerede døgndoser (DDD) af indkøbte lægemidler.

Der er to diagramtyper: prik- og seriediagrammer:

Prikdiagrammer viser det forbrugsfordelingen mellem de seks antibiotikahovedgrupper inden for deseneste seks måneder.

Seriediagrammer viser udviklingen over tid (siden 2014) – dels det relative forbrug mellem de seksantibiotikagrupper dels totalforbruget opgjort i DDD per 100 sengedage og endelig totalforbruget i DDDfor de 12 mest købte antibiotika på den pågældende afdeling.

Hvis seriediagrammets mindtlinje (medianen) er rød, tyder det på ikke-tilfældig variation i forbruget overtid, fx at forbruget er stigende eller faldende.

Lidt forenklet kan man sige, at prikdiagrammerne viser, hvor vi er lige nu (niveauet), mens seriediagram-merne viser, hvordan vi er kommet hertil (retningen).

6

Bispebjerg og Frederiksberg Hospitaler

1.4%

1.7%

9%

1.1%

6.5%

8.1%

10%

62%

tetracycliner

aminoglycosid antibacterica

macrolider, lincosamider og streptograminer

sulfonamider og trimethoprim

andre antibacterica

quinolon antibacterica

andre beta−lactam antibacterica

beta−lactam antibakterica, penicilliner

0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, nov 2015 − apr 2016

60

12

9 7

1 7

2 2

beta−lactam antibakterica, penicilliner andre beta−lactam antibacterica

quinolon antibacterica andre antibacterica

sulfonamider og trimethoprim macrolider, lincosamider og streptograminer

aminoglycosid antibacterica tetracycliner

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, Bispebjerg og Frederiksberg Hospitaler

7

18801

15000

17500

20000

22500

25000

27500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH

2940 1935

1891 1472

1462 1384

1414

840

678

656

468 394

pivmecillinam amoxicillin og enzym−inhibitor

piperacillin og enzym−hæmmer ciprofloxacin

flucloxacillin cefuroxim

phenoxymethylpenicillin metronidazol

dicloxacillin meropenem

clarithromycin pivampicillin

2000

2500

3000

3500

4000

1000

1500

2000

2500

3000

3500

1500

2000

2500

3000

1000

1500

2000

1200

1600

2000

1200

1500

1800

1000

1500

2000

800

1000

1200

200

400

600

800

1000

400

600

800

1000

1200

200

400

600

800

1000

250

500

750

1000

1250

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH

8

-

0%

0%

0%

0%

0%

100%

0%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, −, nov 2015 − apr 2016

0 0

100

0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, −

9

00

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, −

0 0

0 0

0 0

0 0

0 0

0 0

ciprofloxacin amoxicillin

ampicillin daptomycin

fosfomycin doripenem

cefepim minocyclin

pristinamycin spiramycin

sulfapyridin teicoplanin

0

5

10

15

20

0

10

20

30

0

1

2

3

0.0

0.4

0.8

1.2

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, −

10

Abdominalcenter K

0.24%

1%

3.5%

0.49%

24%

14%

11%

46%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Abdominalcenter K, nov 2015 − apr 2016

46

11

15

24

0 4

1 0





0%

10%

20%

30%

40%

50%

0%

10%

20%

30%

40%

50%

0%

10%

20%

30%

40%

50%

0%

10%

20%

30%

40%

50%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Abdominalcenter K

11

1866

1500

2000

2500

3000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Abdominalcenter K

413

331

273 247

138 82

69 53

50 49

25 33

metronidazol piperacillin og enzym−hæmmer

ciprofloxacin pivmecillinam

cefuroxim amoxicillin og enzym−inhibitor

phenoxymethylpenicillin clarithromycin

amoxicillin meropenem

flucloxacillin vancomycin

300

400

500

300

400

500

200

300

400

500

100

200

300

400

500

100

150

200

40

80

120

160

0

50

100

150

200

0

50

100

150

0

30

60

90

0

50

100

0

25

50

75

100

20

40

60

80

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Abdominalcenter K

12

Akutmodtagelsen

0.08%

0.64%

11%

0.24%

2.8%

5.6%

3.9%

76%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Akutmodtagelsen, nov 2015 − apr 2016

76

4

7 3

0 8

1 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Akutmodtagelsen

13

1862

1600

2000

2400

2800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Akutmodtagelsen

380 276

262

219

107 88

65 60

47 48

32 25

pivmecillinam phenoxymethylpenicillin

amoxicillin og enzym−inhibitor piperacillin og enzym−hæmmer

ciprofloxacin dicloxacillin

clarithromycin roxithromycin

benzylpenicillin metronidazol

moxifloxacin flucloxacillin

200

300

400

500

600

700

200

300

400

500

100

200

300

400

150

200

250

300

350

50

100

150

200

0

50

100

150

200

0

50

100

150

200

250

0

50

100

150

200

25

50

75

20

40

60

25

50

75

0

25

50

75

100

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Akutmodtagelsen

14

Anæstesiafdeling Z

0%

0.84%

5.9%

0.9%

21%

22%

30%

20%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Anæstesiafdeling Z, nov 2015 − apr 2016

21

31

21 18

0 5

0 0





0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Anæstesiafdeling Z

15

766

600

800

1000

1200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Anæstesiafdeling Z

186

147

123 113

102 28

18

20

11

0

8 0

ciprofloxacin cefuroxim

piperacillin og enzym−hæmmer metronidazol

meropenem vancomycin

dicloxacillin erythromycin

benzylpenicillin sulfamethoxazol og trimethoprim

clarithromycin phenoxymethylpenicillin

100

150

200

250

300

100

150

200

50

100

150

200

50

100

150

200

50

100

150

200

20

40

60

0

20

40

60

80

0

10

20

30

40

0

20

40

60

0

20

40

60

0

25

50

75

0

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Anæstesiafdeling Z

16

Dermato-Venerologisk Afdeling og Videncenter for Sårheling

7.5%

0.046%

32%

0.38%

0.98%

6.4%

2.4%

50%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Dermato−Venerologisk Afdeling og Videncenter for Sårheling, nov 2015 − apr 2016

54

3

6 1

0

19

0

14





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Dermato−Venerologisk Afdeling og Videncenter for Sårheling

17

2325

1500

2000

2500

3000

3500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Dermato−Venerologisk Afdeling og Videncenter for Sårheling

638

300

100

213

134

100

105 67

45

44

30 27

flucloxacillin doxycyclin

azithromycin phenoxymethylpenicillin

clindamycin ciprofloxacin

dicloxacillin benzylpenicillin


roxithromycin pivmecillinam

400

600

800

1000

0

500

1000

1500

0

200

400

600

800

0

100

200

300

400

100

200

300

50

100

150

0

50

100

150

200

0

50

100

150

0

50

100

150

200

250

0

25

50

75

0

50

100

0

30

60

90

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Dermato−Venerologisk Afdeling og Videncenter for Sårheling

18

Endokrinologisk Afdeling I

0%

0.08%

4.3%

0.74%

6.9%

6.6%

5.8%

76%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Endokrinologisk Afdeling I, nov 2015 − apr 2016

71

6

8 8

0 3

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Endokrinologisk Afdeling I

19

727

500

750

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Endokrinologisk Afdeling I

200 133

68

61

33 33

20 25

6 14

14 10

pivmecillinam piperacillin og enzym−hæmmer

amoxicillin og enzym−inhibitor ciprofloxacin


meropenem flucloxacillin

clarithromycin dicloxacillin

pivampicillin cefuroxim

100

200

300

0

50

100

150

200

250

0

50

100

150

200

0

30

60

90

0

25

50

75

0

25

50

75

100

0

25

50

75

100

0

20

40

60

0

20

40

60

0

20

40

60

0

20

40

60

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Endokrinologisk Afdeling I

20

Geriatrisk Afdeling G

0%

0.21%

4.6%

0.53%

3.5%

5.7%

6.8%

79%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Geriatrisk Afdeling G, nov 2015 − apr 2016

76

12

5 4

0 3

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Geriatrisk Afdeling G

21

1317

1000

1500

2000

2500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Geriatrisk Afdeling G

303 210

177 120

104 56

62

50

28

18

21 23


piperacillin og enzym−hæmmer cefuroxim

phenoxymethylpenicillin pivampicillin

ciprofloxacin flucloxacillin

meropenem clarithromycin

dicloxacillin metronidazol

200

400

600

800

100

200

300

400

100

200

300

50

100

150

200

250

100

200

300

100

200

50

100

150

200

250

0

25

50

75

100

0

20

40

60

0

20

40

60

80

0

20

40

60

80

0

20

40

60

80

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Geriatrisk Afdeling G

22

Hjerteafdeling Y

0.21%

0.55%

5.1%

0.55%

3.6%

8.9%

11%

70%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Hjerteafdeling Y, nov 2015 − apr 2016

69

13

9 3

0 3

1 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Hjerteafdeling Y

23

1202

1000

1500

2000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Hjerteafdeling Y

172 127

129 109

96

97

75

51

51

52

8

25

amoxicillin og enzym−inhibitor pivmecillinam

piperacillin og enzym−hæmmer phenoxymethylpenicillin

cefuroxim ciprofloxacin

flucloxacillin benzylpenicillin


ampicillin roxithromycin

100

150

200

250

300

100

200

300

400

100

200

0

100

200

40

80

120

160

50

100

150

200

0

50

100

150

0

50

100

150

200

0

50

100

150

200

0

30

60

90

0

50

100

150

0

25

50

75

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Hjerteafdeling Y

24

Lungemedicinsk Afdeling L

0.47%

0.42%

11%

4.4%

5.1%

14%

12%

53%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Lungemedicinsk Afdeling L, nov 2015 − apr 2016

52

10

17

4

2

12

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Lungemedicinsk Afdeling L

25

1987

1500

2000

2500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Lungemedicinsk Afdeling L

458 242

233

189

141 84

80 79

53

25

14

50


ciprofloxacin clarithromycin

meropenem moxifloxacin


metronidazol sulfamethoxazol og trimethoprim

pivampicillin flucloxacillin

300

400

500

600

200

250

300

350

100

150

200

250

300

100

150

200

250

300

100

200

300

50

100

150

0

50

100

150

200

0

50

100

150

200

25

50

75

100

125

0

100

200

300

0

50

100

150

200

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Lungemedicinsk Afdeling L

26

Medicinsk Afdeling C

0.17%

8%

8.5%

0.85%

4.4%

3.8%

8.9%

65%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Medicinsk Afdeling C, nov 2015 − apr 2016

56

21

5 3

0 6

9

0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Medicinsk Afdeling C

27

2040

1500

2000

2500

3000

3500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Medicinsk Afdeling C

285

322

292 198

96

103

115

43

75 62

50 49

amoxicillin og enzym−inhibitor cefuroxim



tobramycin gentamicin



200

400

600

800

0

100

200

300

400

500

100

200

300

400

500

100

200

300

100

200

300

50

100

150

200

0

100

200

0

100

200

0

50

100

150

40

60

80

100

120

0

50

100

150

200

250

0

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Medicinsk Afdeling C

28

Neurologisk Afdeling N

0.61%

0.34%

0.32%

1.7%

7.7%

4%

7.7%

78%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Neurologisk Afdeling N, nov 2015 − apr 2016

71

9

4 9

1 2

0 1





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Neurologisk Afdeling N

29

816

300

600

900

1200

1500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Neurologisk Afdeling N

267 127

75 53

31 31

30 25

24 14

6 3


amoxicillin og enzym−inhibitor metronidazol

phenoxymethylpenicillin ciprofloxacin

cefuroxim flucloxacillin

meropenem pivampicillin


100

200

300

400

500

50

100

150

200

250

50

100

25

50

75

100

0

50

100

0

25

50

75

100

0

25

50

75

0

20

40

60

0

20

40

60

0

20

40

60

0

20

40

60

0

25

50

75

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Neurologisk Afdeling N

30

Ortopædkirurgisk Afdeling M

0.29%

2.7%

1.5%

0.18%

5%

5.1%

23%

62%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Ortopædkirurgisk Afdeling M, nov 2015 − apr 2016

62

23

5 5

0 1

3 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Ortopædkirurgisk Afdeling M

31

2361

1500

2000

2500

3000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Ortopædkirurgisk Afdeling M

422 338

273 219

186 193

94 74

77 60

64

49


pivmecillinam dicloxacillin


ciprofloxacin meropenem

benzylpenicillin amoxicillin og enzym−inhibitor

gentamicin pivampicillin

200

300

400

500

600

200

300

400

500

100

200

300

400

100

200

300

100

150

200

250

300

100

200

300

50

100

150

200

0

50

100

150

200

0

50

100

150

200

0

50

100

150

0

50

100

0

100

200

300

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Ortopædkirurgisk Afdeling M

32

Ortopædkirurgisk Afdeling O

0%

0.3%

1.7%

0.27%

1.8%

7.4%

12%

77%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Ortopædkirurgisk Afdeling O, nov 2015 − apr 2016

64

16

6 2

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Ortopædkirurgisk Afdeling O

33

174

100

200

300

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Ortopædkirurgisk Afdeling O

50

30

27

5

5 0

0 0

3 0

0 0



phenoxymethylpenicillin moxifloxacin

ciprofloxacin pivampicillin

vancomycin nitrofurantoin

amoxicillin linezolid

0

50

100

150

200

0

20

40

60

0

20

40

60

0

30

60

90

0

20

40

60

0

20

40

60

80

0

10

20

30

40

0

10

20

30

0

5

10

15

20

0

10

20

30

40

50

0

20

40

60

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Ortopædkirurgisk Afdeling O

34

Palliativ Medicinsk Afdeling P

1.5%

0.73%

5.1%

4.4%

6.3%

8.2%

7.3%

67%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Palliativ Medicinsk Afdeling P, nov 2015 − apr 2016

56

10

11 7

0 0

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Palliativ Medicinsk Afdeling P

35

125

100

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Palliativ Medicinsk Afdeling P

20 17

10 8

5 0

0

4

0 0

0 0


ciprofloxacin amoxicillin og enzym−inhibitor

meropenem metronidazol

ampicillin cefuroxim


dicloxacillin roxithromycin

0

20

40

60

80

0

20

40

60

0

20

40

60

0

10

20

30

40

0

10

20

30

40

0

10

20

30

40

0

10

20

30

0

5

10

15

0

5

10

15

20

0

5

10

15

20

25

0

5

10

15

20

0.0

2.5

5.0

7.5

10.0

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Palliativ Medicinsk Afdeling P

36

Reumatologisk Afdeling H

tetracycliner




andre antibacterica




50% 75% 100% 125% 150%

Relativt forbrug af antibakterielle midler BH, Reumatologisk Afdeling H, nov 2015 − apr 2016

66

19

0 4

1 0

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Reumatologisk Afdeling H

37

00

100

200

300

400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Reumatologisk Afdeling H

0 0

0 0

0 0

0 0

0 0

0 0

pivmecillinam cefuroxim


flucloxacillin metronidazol

phenoxymethylpenicillin pivampicillin


trimethoprim dicloxacillin

0

30

60

90

0

20

40

60

80

0

20

40

60

0

10

20

30

0

5

10

15

20

25

0

10

20

30

0

10

20

30

40

0

10

20

30

40

50

0

10

20

30

0

10

20

0

5

10

15

20

25

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Reumatologisk Afdeling H

38

Urologisk Afdeling U

3.3%

3.1%

0.12%

2.4%

1.2%

5%

3.1%

82%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BH, Urologisk Afdeling U, nov 2015 − apr 2016

78

3

6 2

3 0

3 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BH, Urologisk Afdeling U

39

1211

1000

1500

2000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BH, Urologisk Afdeling U

518 185

74

84

46 25

22 21

0 12

10 11


ciprofloxacin piperacillin og enzym−hæmmer

pivampicillin trimethoprim


doxycyclin tobramycin

gentamicin amoxicillin

250

500

750

0

200

400

600

0

100

200

300

400

40

80

120

160

0

50

100

150

200

0

30

60

90

0

50

100

0

25

50

75

100

0

50

100

150

200

0

25

50

75

100

0

20

40

60

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BH, Urologisk Afdeling U

40

Bornholms Hospital

0.21%

1.1%

8%

1.4%

5.6%

7.3%

12%

64%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, nov 2015 − apr 2016

51

27

11 5

2 5

1 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, Bornholms Hospital

41

25172500

3000

3500

4000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO

549 313

255 241

225

90

125 97

87 95

84

67

cefuroxim pivmecillinam

ciprofloxacin phenoxymethylpenicillin



benzylpenicillin meropenem

pivampicillin clarithromycin

250

500

750

1000

200

400

600

100

200

300

400

500

100

200

300

400

0

100

200

300

400

100

200

300

400

0

50

100

150

200

250

50

100

150

200

50

100

150

50

100

150

0

50

100

150

200

0

100

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO

42

Akutmodtagelse

0%

0.65%

7.3%

0%

1.3%

3.9%

3.5%

83%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Akutmodtagelse, nov 2015 − apr 2016

79

6

4 0

0 7

2 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Akutmodtagelse

43

304

200

300

400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Akutmodtagelse

106

53

25 15

15

15

15

10

0 3

2 0

phenoxymethylpenicillin pivmecillinam

flucloxacillin amoxicillin


roxithromycin ciprofloxacin

pivampicillin tobramycin

azithromycin piperacillin og enzym−hæmmer

0

50

100

150

0

50

100

150

200

0

20

40

60

0

25

50

75

0

20

40

60

0

10

20

30

0

10

20

30

0

10

20

30

40

0

20

40

60

0

5

10

15

20

0

5

10

15

20

0

5

10

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Akutmodtagelse

44

Apoteket/Nødberedskab

0%

0%

7.3%

9.1%

1.5%

0%

6.4%

76%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Apoteket/Nødberedskab, nov 2015 − apr 2016

66

20

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Apoteket/Nødberedskab

45

22

0

100

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Apoteket/Nødberedskab

0 0

0 0

0 0

0 0

0 0

0 0

cefuroxim benzylpenicillin

piperacillin og enzym−hæmmer dicloxacillin

cloxacillin meropenem

ampicillin pivmecillinam

trimethoprim phenoxymethylpenicillin

ceftriaxon azithromycin

0

50

100

150

200

250

0

10

20

30

40

0

20

40

0

5

10

15

20

0

20

40

60

0

5

10

15

20

25

0

5

10

15

0

10

20

0

5

10

15

20

25

0

5

10

15

20

0.0

2.5

5.0

7.5

10.0

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Apoteket/Nødberedskab

46

Dialyseafsnit F2

0%

0%

0%

0%

51%

0%

49%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Dialyseafsnit F2, nov 2015 − apr 2016

0 0

0

100

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Dialyseafsnit F2

47

10

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Dialyseafsnit F2

0 0

0 0

0 0

0 0

0 0

0 0

vancomycin cefuroxim


cefepim minocyclin



levofloxacin lymecyclin

0

5

10

0.0

2.5

5.0

7.5

10.0

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Dialyseafsnit F2

48

Endagsafsnit A.O

0%

0%

0%

0%

0%

0%

0%

100%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Endagsafsnit A.O, nov 2015 − apr 2016

100

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Endagsafsnit A.O

49

00

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Endagsafsnit A.O

0 0

0 0

0 0

0 0

0 0

0 0



cefepim minocyclin




0

10

20

30

0.0

2.5

5.0

7.5

10.0

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Endagsafsnit A.O

50

Hjerteafsnit F0-1

0%

0%

15%

0%

0%

6.9%

0%

78%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Hjerteafsnit F0−1, nov 2015 − apr 2016

80

0

8 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Hjerteafsnit F0−1

51

74

0

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Hjerteafsnit F0−1

15 13

10 5

0 0

0 0

0 0

0 0



pivampicillin clarithromycin

flucloxacillin clindamycin

roxithromycin moxifloxacin

benzylpenicillin amoxicillin

0

20

40

60

0

20

40

60

0

10

20

30

40

0

10

20

30

0

10

20

30

40

50

0

10

20

30

40

0

5

10

15

20

25

0

10

20

30

0

5

10

15

20

0

5

10

0

5

10

15

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Hjerteafsnit F0−1

52

Hjerteafsnit F0-2

0%

1.7%

9.7%

0%

4.1%

5%

8.1%

71%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Hjerteafsnit F0−2, nov 2015 − apr 2016

54

29

10 4

0 3

2 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Hjerteafsnit F0−2

53

366

300

400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Hjerteafsnit F0−2

86

35

19

30

33

22

15

25

15

14

11

0



pivmecillinam benzylpenicillin

amoxicillin og enzym−inhibitor flucloxacillin

meropenem pivampicillin

dicloxacillin clarithromycin

0

50

100

150

0

30

60

90

120

0

25

50

75

100

125

0

25

50

75

0

20

40

60

0

50

100

0

20

40

60

0

10

20

30

40

50

0

10

20

30

0

20

40

60

0

10

20

30

40

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Hjerteafsnit F0−2

54

Intensiv

0%

1.7%

6.3%

0%

12%

15%

25%

40%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Intensiv, nov 2015 − apr 2016

22 30

21 15

0 0

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Intensiv

55

68

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Intensiv

13 12

10

7

4

0

0 0

0 0

0 0


meropenem metronidazol

piperacillin og enzym−hæmmer sulfamethoxazol og trimethoprim

benzylpenicillin pivmecillinam

vancomycin ampicillin

amoxicillin clarithromycin

0

10

20

30

40

50

0

10

20

30

40

0

10

20

30

0

10

20

30

40

50

0

5

10

15

0

10

20

30

40

50

0

5

10

15

20

0

10

20

30

0.0

2.5

5.0

7.5

10.0

12.5

0

5

10

15

0

10

20

30

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Intensiv

56

Kirurgisk afdeling A.1.1

0%

0.48%

4.4%

0.74%

8.8%

7%

18%

61%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Kirurgisk afdeling A.1.1, nov 2015 − apr 2016

46

33

9 9

0 3

1 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Kirurgisk afdeling A.1.1

57

608

400

600

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Kirurgisk afdeling A.1.1

180 107

49 50

47

24

30

15

20

11

14 9




phenoxymethylpenicillin amoxicillin og enzym−inhibitor

pivampicillin dicloxacillin

clarithromycin benzylpenicillin

100

200

300

0

50

100

150

200

0

30

60

90

120

0

25

50

75

100

0

20

40

60

80

0

30

60

90

0

20

40

60

0

20

40

60

0

20

40

0

25

50

75

0

20

40

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Kirurgisk afdeling A.1.1

58

Kirurgisk ambulatorium D.0

0%

0.52%

0%

0%

0%

55%

0%

44%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Kirurgisk ambulatorium D.0, nov 2015 − apr 2016

0 0

88

0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Kirurgisk ambulatorium D.0

59

00

30

60

90

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Kirurgisk ambulatorium D.0

0 0

0 0

0

0

0 0

0 0

0 0


sulfamethizol gentamicin

vancomycin fosfomycin

doripenem cefepim

minocyclin pristinamycin

spiramycin sulfapyridin

0

25

50

75

100

0

10

20

30

40

0

1

2

3

0.0

0.1

0.2

0.3

0.4

0.0

0.1

0.2

0.3

0.4

0.5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Kirurgisk ambulatorium D.0

60

Medicinsk ambulatorium A.O

0%

0%

86%

0%

0%

0%

14%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Medicinsk ambulatorium A.O, nov 2015 − apr 2016

0 0

0

100

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Medicinsk ambulatorium A.O

61

00

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Medicinsk ambulatorium A.O

0 0

0 0

0 0

0 0

0 0

0 0

clindamycin vancomycin

sulfamethoxazol og trimethoprim ceftriaxon


cefepim minocyclin



0

20

40

60

0

5

10

15

0

5

10

15

20

25

0.0

2.5

5.0

7.5

10.0

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Medicinsk ambulatorium A.O

62

MKO amb/CYTO

15%

0%

0%

76%

0%

0%

0%

9.1%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, MKO amb/CYTO, nov 2015 − apr 2016

0 0

0 0

83

0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, MKO amb/CYTO

63

130

200

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, MKO amb/CYTO

0 0

0 0

0 0

0 0

0 0

0

0

doxycyclin sulfamethoxazol og trimethoprim

dicloxacillin cefuroxim

amoxicillin og enzym−inhibitor tetracyclin

daptomycin piperacillin og enzym−hæmmer

vancomycin ciprofloxacin

metronidazol fosfomycin

0

100

200

300

400

500

0

20

40

60

0

10

20

30

0

10

20

30

40

0

10

20

30

0

5

10

15

20

25

0

5

10

15

0

5

10

0

2

4

6

0

2

4

6

8

0

2

4

6

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, MKO amb/CYTO

64

MKO seng

0.25%

1.6%

9.3%

1.2%

4.3%

10%

13%

60%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, MKO seng, nov 2015 − apr 2016

49

24

13 4

3 3

2 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, MKO seng

65

693

600

800

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, MKO seng

148 120

87 53

37 30

7

33

17

19

25 17



piperacillin og enzym−hæmmer meropenem


pivampicillin benzylpenicillin


0

50

100

150

200

0

50

100

150

200

50

100

150

0

50

100

150

30

60

90

120

0

30

60

90

120

0

50

100

150

0

25

50

75

0

30

60

90

0

10

20

30

40

0

10

20

30

40

50

0

10

20

30

40

50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, MKO seng

66

Neurologisk og Børneafs F1-1

0%

0%

17%

1%

0%

7%

0%

75%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Neurologisk og Børneafs F1−1, nov 2015 − apr 2016

77

0

10 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Neurologisk og Børneafs F1−1

67

70

0

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Neurologisk og Børneafs F1−1

27 10

0 5

0 0

0 0

0 0

0 0



flucloxacillin pivampicillin

clarithromycin trimethoprim

nitrofurantoin sulfamethoxazol og trimethoprim

sulfamethizol cefuroxim

0

20

40

60

80

0

10

20

30

40

0

10

20

30

40

0

10

20

30

0

5

10

15

20

25

0

10

20

30

0

20

40

60

0

5

10

15

20

25

0

5

10

15

20

25

0

5

10

15

20

25

0

2

4

6

0

2

4

6

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Neurologisk og Børneafs F1−1

68

Neurologisk og Børneafs F1-2

0%

0.8%

7.8%

0.29%

8.5%

5.1%

9.6%

68%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, Neurologisk og Børneafs F1−2, nov 2015 − apr 2016

56

30

5 6

0 0

2 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, Neurologisk og Børneafs F1−2

69

247

200

300

400

500

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, Neurologisk og Børneafs F1−2

59 27

14 15

17 14

10 15

13 11

8 8



phenoxymethylpenicillin benzylpenicillin

meropenem amoxicillin

metronidazol dicloxacillin

ampicillin amoxicillin og enzym−inhibitor

0

50

100

150

200

0

20

40

60

80

0

25

50

75

0

25

50

75

0

20

40

0

10

20

30

40

50

0

10

20

30

40

0

10

20

30

40

0

10

20

30

0

10

20

30

40

0

10

20

30

40

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, Neurologisk og Børneafs F1−2

70

OP/Anæstesi

0%

10%

0%

0%

16%

0%

72%

2.2%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler BO, OP/Anæstesi, nov 2015 − apr 2016

0

79

0 0

0 0

3 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, BO, OP/Anæstesi

71

41

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, BO, OP/Anæstesi

32

0

1

0

0 0

0 0

0 0

0 0

cefuroxim metronidazol

gentamicin tobramycin

pivampicillin pivmecillinam

piperacillin og enzym−hæmmer amoxicillin

benzylpenicillin clindamycin


10

20

30

40

50

0

10

20

30

0

1

2

3

4

0

5

10

15

0

5

10

15

20

0

5

10

0

1

2

0

1

2

3

4

5

0

1

2

3

0.0

0.5

1.0

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, BO, OP/Anæstesi

72

Herlev og Gentofte Hospital

2.1%

3.2%

6.8%

4.5%

6.9%

5.4%

6.4%

65%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, nov 2015 − apr 2016

64

7

5 7

4 6

3 2





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, Herlev og Gentofte Hospital

73

32305

30000

35000

40000

45000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE

4657 3058

2940 2343

1826

1747

1625 1570

1512

1391

1362

1162


phenoxymethylpenicillin piperacillin og enzym−hæmmer


metronidazol ciprofloxacin

ampicillin flucloxacillin

clarithromycin sulfamethoxazol og trimethoprim

3500

4000

4500

5000

5500

6000

3000

4000

2000

3000

4000

5000

6000

2000

2500

3000

500

1000

1500

2000

2500

1500

2000

1250

1500

1750

2000

2250

1000

1500

2000

2500

1000

1500

2000

2500

3000

750

1000

1250

1500

1750

500

1000

1500

2000

1000

2000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE

74

-

tetracycliner




andre antibacterica




50% 75% 100% 125% 150%

Relativt forbrug af antibakterielle midler HE, −, nov 2015 − apr 2016

68

7

4 4

1 10

1 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, −

75

7169

0

5000

10000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, −

885

720

660

413

418 302

382 327

175 190

202

142


amoxicillin og enzym−inhibitor clarithromycin



flucloxacillin ampicillin

ciprofloxacin metronidazol

0

1000

2000

3000

0

300

600

900

1200

0

500

1000

0

500

1000

1500

0

500

1000

0

200

400

600

0

200

400

600

0

200

400

600

0

200

400

600

0

200

400

600

0

100

200

300

400

0

200

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, −

76

Akutmodtagelsen A

0%

15%

7.1%

1%

5.9%

0.57%

3.3%

67%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Akutmodtagelsen A, nov 2015 − apr 2016

65

3

1 6

2 7

15

0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Akutmodtagelsen A

77

970

750

1000

1250

1500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Akutmodtagelsen A

227 153

133 71

57 50

33 30

30

25

0

20


gentamicin benzylpenicillin

ampicillin metronidazol

piperacillin og enzym−hæmmer amoxicillin og enzym−inhibitor

azithromycin flucloxacillin

tobramycin clarithromycin

200

300

400

100

150

200

0

100

200

300

30

60

90

120

20

40

60

80

100

25

50

75

100

20

30

40

50

60

0

25

50

75

100

20

40

60

0

50

100

150

0

50

100

150

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Akutmodtagelsen A

78

Anæstesiologisk I

0%

16%

3.9%

0.53%

12%

4.6%

9.6%

54%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Anæstesiologisk I, nov 2015 − apr 2016

54

8

4

13

1 4

17

0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Anæstesiologisk I

79

2454

1500

2000

2500

3000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Anæstesiologisk I

307 335

257 248

192 156

135

120

98

0

100 71

pivmecillinam gentamicin

metronidazol phenoxymethylpenicillin

ampicillin piperacillin og enzym−hæmmer


ciprofloxacin tobramycin


100

200

300

400

500

600

0

250

500

750

1000

200

300

400

100

200

300

400

100

150

200

250

300

125

150

175

200

0

50

100

150

200

0

50

100

150

200

50

100

150

200

0

100

200

300

400

0

50

100

150

200

40

80

120

160

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Anæstesiologisk I

80

Anæstesiologisk Q

0%

0.48%

5.2%

0%

15%

13%

23%

44%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Anæstesiologisk Q, nov 2015 − apr 2016

41

22

13 15

0 6

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Anæstesiologisk Q

81

00

200

400

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Anæstesiologisk Q

0 0

0 0

0 0

0 0

0 0

0 0

dicloxacillin ciprofloxacin


cefuroxim meropenem

phenoxymethylpenicillin vancomycin

clarithromycin roxithromycin

erythromycin benzylpenicillin

0

50

100

150

200

0

50

100

0

25

50

75

100

125

0

20

40

60

80

0

20

40

60

0

25

50

75

100

0

10

20

30

0

10

20

30

40

0

5

10

15

20

25

0

5

10

15

20

0

5

10

15

0

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Anæstesiologisk Q

82

Brystkirurgisk F

0%

9.6%

0%

0%

2.9%

0%

6.5%

81%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Brystkirurgisk F, nov 2015 − apr 2016

81

7

0 3

0 0

9 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Brystkirurgisk F

83

00

100

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Brystkirurgisk F

0 0

0 0

0 0

0 0

0

0

0 0

dicloxacillin gentamicin

cefuroxim piperacillin og enzym−hæmmer

vancomycin flucloxacillin

metronidazol benzylpenicillin

ampicillin fosfomycin

doripenem cefepim

0

50

100

150

0

10

20

30

40

50

0

10

20

30

0.0

2.5

5.0

7.5

0

2

4

6

0

5

10

15

20

25

0

2

4

6

0

1

2

3

0.00

0.25

0.50

0.75

1.00

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Brystkirurgisk F

84

Børneafdeling E

0%

4.9%

7.4%

0.3%

0.9%

2.7%

7.4%

76%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Børneafdeling E, nov 2015 − apr 2016

76

11

1 0

0 4

5 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Børneafdeling E

85

494

300

400

500

600

700

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Børneafdeling E

134

58

44 39

38 32

22

26

19 12

6 0

ampicillin benzylpenicillin

phenoxymethylpenicillin dicloxacillin

amoxicillin og enzym−inhibitor amoxicillin

cefuroxim gentamicin

clarithromycin meropenem

flucloxacillin pivmecillinam

50

100

150

200

40

80

120

30

60

90

0

25

50

75

0

30

60

90

120

20

40

60

20

40

60

0

10

20

30

40

50

0

20

40

0

10

20

30

0

10

20

30

40

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Børneafdeling E

86

Gastroenheden D

0.054%

0.87%

2.5%

0.61%

31%

6.2%

8.6%

50%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Gastroenheden D, nov 2015 − apr 2016

50

8

6

31

0 2

1 0





0%

20%

40%

0%

20%

40%

0%

20%

40%

0%

20%

40%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Gastroenheden D

87

15371500

1750

2000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Gastroenheden D

453 411

140 98

60 55

50 46

45 25

24 20


pivmecillinam ciprofloxacin

cefuroxim meropenem

amoxicillin og enzym−inhibitor phenoxymethylpenicillin

amoxicillin flucloxacillin

vancomycin clarithromycin

300

400

500

600

300

400

500

100

200

50

100

150

0

50

100

150

40

80

120

0

40

80

120

0

25

50

75

100

0

25

50

75

100

125

0

50

100

25

50

75

0

30

60

90

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Gastroenheden D

88

Gyn.-Obs G

1.2%

1%

6.1%

0.65%

13%

0.86%

7.7%

70%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Gyn.−Obs G, nov 2015 − apr 2016

74

6

0 10

0 4

1 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Gyn.−Obs G

89

670

400

600

800

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Gyn.−Obs G

127 113

67 60

60

31

26 20

20

12

0

10

pivmecillinam pivampicillin


benzylpenicillin dicloxacillin


phenoxymethylpenicillin flucloxacillin

amoxicillin og enzym−inhibitor azithromycin

50

100

150

200

0

100

200

50

100

150

40

80

120

160

30

60

90

0

50

100

0

20

40

60

80

10

20

30

40

0

10

20

30

40

50

0

20

40

60

0

25

50

75

100

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Gyn.−Obs G

90

Hjertemedicinsk S

0%

1%

12%

0.14%

3.3%

0.34%

13%

70%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Hjertemedicinsk S, nov 2015 − apr 2016

71

20

0 3

0 5

2 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Hjertemedicinsk S

91

00

200

400

600

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Hjertemedicinsk S

0 0

0 0

0 0

0 0

0 0

0 0

benzylpenicillin pivmecillinam



dicloxacillin phenoxymethylpenicillin

clarithromycin meropenem

flucloxacillin gentamicin

0

50

100

150

0

50

100

150

200

0

50

100

0

25

50

75

100

0

50

100

0

25

50

75

0

25

50

75

100

125

0

25

50

75

100

0

100

200

0

20

40

60

80

0

5

10

15

20

25

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Hjertemedicinsk S

92

Hud- Og Allergiafdeling U

0%

0.37%

4.9%

1.2%

7.5%

10%

11%

65%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Hud− Og Allergiafdeling U, nov 2015 − apr 2016

69

10

7 6

1 3

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Hud− Og Allergiafdeling U

93

685

400

800

1200

1600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Hud− Og Allergiafdeling U

101

50

56

67

59

38

25 30

30 31

25 25

benzylpenicillin ampicillin

dicloxacillin pivmecillinam


meropenem moxifloxacin


linezolid flucloxacillin

0

100

200

300

0

100

200

300

400

0

100

200

300

0

25

50

75

100

125

30

60

90

25

50

75

100

0

50

100

150

0

50

100

0

25

50

75

100

10

20

30

40

50

60

0

30

60

90

120

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Hud− Og Allergiafdeling U

94

Hæmatologisk L

0.097%

0.32%

4.9%

23%

2.5%

14%

7.5%

47%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Hæmatologisk L, nov 2015 − apr 2016

39

8

16

4

18

8

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Hæmatologisk L

95

3991

3000

4000

5000

6000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Hæmatologisk L

750 735

636

90

230 211

169 85

66 75

51

50

sulfamethoxazol og trimethoprim amoxicillin og enzym−inhibitor


meropenem piperacillin og enzym−hæmmer

clarithromycin pivmecillinam

clindamycin flucloxacillin

vancomycin azithromycin

0

500

1000

1500

2000

2500

500

750

1000

1250

1500

200

400

600

800

1000

0

500

1000

1500

2000

100

200

300

400

150

200

250

300

0

100

200

300

400

0

50

100

150

200

50

100

150

200

0

50

100

150

200

25

50

75

100

0

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Hæmatologisk L

96

Lungemedicinsk Y

3.1%

2.6%

13%

1.3%

1.1%

9.2%

7.7%

62%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Lungemedicinsk Y, nov 2015 − apr 2016

64

8

8 1

1

12

0 2





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Lungemedicinsk Y

97

00

500

1000

1500

2000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Lungemedicinsk Y

0 0

0 0

0 0

0 0

0 0

0 0


piperacillin og enzym−hæmmer clarithromycin


moxifloxacin pivmecillinam


doxycyclin azithromycin

0

200

400

600

800

0

50

100

150

200

0

50

100

150

0

50

100

150

200

0

50

100

0

25

50

75

0

25

50

75

100

0

30

60

90

0

20

40

0

20

40

60

0

25

50

75

100

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Lungemedicinsk Y

98

Medicinsk Afdeling O

0.24%

1.5%

16%

0.77%

6.4%

5.5%

4.4%

65%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Medicinsk Afdeling O, nov 2015 − apr 2016

74

4

4 7

1 6

2 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Medicinsk Afdeling O

99

4678

4000

5000

6000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Medicinsk Afdeling O

627 553

538 418

420

186

250 220

202

200

156 158


benzylpenicillin piperacillin og enzym−hæmmer

amoxicillin clarithromycin

metronidazol ampicillin

amoxicillin og enzym−inhibitor dicloxacillin


300

600

900

300

400

500

600

700

300

400

500

600

700

200

300

400

500

600

200

400

600

800

0

500

1000

1500

150

200

250

300

350

400

200

300

100

200

300

400

0

100

200

300

100

200

300

50

100

150

200

250

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Medicinsk Afdeling O

100

Medicinsk C

0.034%

2.3%

11%

1.2%

7.3%

2.1%

4.9%

71%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Medicinsk C, nov 2015 − apr 2016

0 3

0 10

2 8

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Medicinsk C

101

1220

2000

4000

6000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Medicinsk C

0 0

0 0

0 0

0 0

0 0

0 0




clarithromycin flucloxacillin

metronidazol dicloxacillin

cefuroxim pivampicillin

0

300

600

900

1200

0

250

500

750

0

200

400

600

0

200

400

0

100

200

300

400

0

100

200

300

400

0

100

200

300

400

0

100

200

300

0

100

200

300

0

50

100

150

200

250

0

100

200

300

0

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Medicinsk C

102

Nefrologisk B

0%

0.95%

1.8%

7.1%

6.4%

7.7%

11%

65%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Nefrologisk B, nov 2015 − apr 2016

66

12

5 8

4 2

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Nefrologisk B

103

512

300

400

500

600

700

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Nefrologisk B

86 55

50

30

30 25

32 25

24

20

18 12

piperacillin og enzym−hæmmer pivmecillinam

flucloxacillin meropenem



cefuroxim pivampicillin

vancomycin sulfamethoxazol og trimethoprim

40

80

120

0

30

60

90

120

0

25

50

75

0

25

50

75

100

125

0

25

50

75

0

25

50

75

100

125

0

25

50

75

100

0

25

50

75

100

0

10

20

30

40

0

20

40

60

0

20

40

60

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Nefrologisk B

104

Neurologisk N

0.25%

1.9%

0.96%

16%

12%

0.74%

3.8%

64%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Neurologisk N, nov 2015 − apr 2016

64

4

0

11

15

1

2 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Neurologisk N

105

629

400

600

800

1000

1200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Neurologisk N

187 75

64

50

45 29

25 13

12

0

10

0

pivmecillinam sulfamethoxazol og trimethoprim


amoxicillin og enzym−inhibitor ampicillin



meropenem nitrofurantoin

100

150

200

250

300

0

50

100

150

200

25

50

75

100

20

40

60

0

25

50

75

20

40

60

0

50

100

0

20

40

60

80

0

20

40

60

0

40

80

120

0

10

20

30

40

50

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Neurologisk N

106

Onkologisk R

32%

0.97%

1.9%

4.6%

6.9%

1.7%

3.4%

49%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Onkologisk R, nov 2015 − apr 2016

48

4

2 7

7 1

1

29





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Onkologisk R

107

1659

1500

2000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Onkologisk R

390 227

160 135

100 74

82 38

40 25

37 40

tetracyclin pivmecillinam


sulfamethoxazol og trimethoprim phenoxymethylpenicillin


ampicillin flucloxacillin

benzylpenicillin doxycyclin

300

400

500

600

0

100

200

300

400

100

150

200

250

0

100

200

0

100

200

0

100

200

300

40

80

120

25

50

75

0

30

60

90

0

40

80

120

25

50

75

0

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Onkologisk R

108

Ortopædkirurgisk T

0%

0.25%

2.1%

0.58%

3%

2%

8%

84%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Ortopædkirurgisk T, nov 2015 − apr 2016

84

6

2 4

1 2

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Ortopædkirurgisk T

109

2194

1500

2000

2500

3000

3500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Ortopædkirurgisk T

569

380

325 183

171 108

96 48

34 33

25 20

dicloxacillin pivmecillinam

flucloxacillin phenoxymethylpenicillin

benzylpenicillin cefuroxim


ampicillin vancomycin

clindamycin pivampicillin

200

400

600

800

200

300

400

500

600

200

400

600

100

200

300

400

100

200

300

50

100

150

200

250

50

100

150

0

30

60

90

0

30

60

90

20

40

60

0

50

100

150

0

20

40

60

80

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Ortopædkirurgisk T

110

Plastikkirurgisk V

0%

0%

8.6%

0.87%

2.4%

6.2%

9.4%

72%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Plastikkirurgisk V, nov 2015 − apr 2016

89

3

0 0

0 4

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Plastikkirurgisk V

111

243

100

200

300

400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Plastikkirurgisk V

150 19

13 15

5 3

0 2

0 3

0 0

flucloxacillin dicloxacillin


cefuroxim clindamycin

ciprofloxacin benzylpenicillin


amoxicillin og enzym−inhibitor roxithromycin

100

200

300

0

20

40

60

0

20

40

0

10

20

30

40

50

0

10

20

30

40

0

20

40

0

10

20

30

40

0

10

20

0

20

40

0

5

10

15

20

0

10

20

30

40

0.0

2.5

5.0

7.5

10.0

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Plastikkirurgisk V

112

Urologisk H

2%

4.9%

0.21%

3.7%

3.9%

4.6%

2.9%

78%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HE, Urologisk H, nov 2015 − apr 2016

78

3

5 4

4 0

5 2





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HE, Urologisk H

113

3884

3000

4000

5000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HE, Urologisk H

1400 720

345 171

166

161

150 148

21

95

67 64



ciprofloxacin trimethoprim

pivampicillin gentamicin

benzylpenicillin doxycyclin

cefuroxim dicloxacillin

900

1200

1500

1800

2100

600

800

1000

250

500

750

1000

100

150

200

250

100

200

300

0

100

200

300

400

500

50

100

150

200

250

0

100

200

300

0

100

200

300

0

50

100

150

200

40

60

80

100

0

30

60

90

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HE, Urologisk H

114

Amager og Hvidovre Hospital

0.4%

1.5%

6.8%

2.5%

7.4%

7.2%

8.9%

65%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, nov 2015 − apr 2016

61

12

10 7

2 5

1 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, Amager og Hvidovre Hospital

115

19391

15000

20000

25000

30000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH

2625 2032

1799 1746

1526 1547

1050 1090

951

521

595 500




metronidazol flucloxacillin

dicloxacillin pivampicillin


2000

2500

3000

3500

4000

2000

3000

4000

1000

1500

2000

2500

3000

1500

2000

2500

800

1200

1600

2000

2400

1000

1500

2000

2500

500

1000

1500

2000

600

900

1200

1500

500

1000

250

500

750

1000

400

600

800

1000

300

400

500

600

700

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH

116

Akutklinik, kir skadeafs team3

0%

0%

13%

0%

0%

0%

0%

87%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Akutklinik, kir skadeafs team3, nov 2015 − apr 2016

90

0

0 0

0 10

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Akutklinik, kir skadeafs team3

117

112

0

100

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Akutklinik, kir skadeafs team3

50

25

0

10

0 0

0

0

0 0

0 0


pivmecillinam roxithromycin

amoxicillin og enzym−inhibitor pivampicillin

gentamicin fosfomycin

doripenem cefepim


0

25

50

75

0

20

40

60

0

20

40

0

10

20

30

0

20

40

60

0

5

10

15

20

0.0

0.5

1.0

1.5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Akutklinik, kir skadeafs team3

118

Akutklinik, obs afs modtagelse

0%

4.2%

0.64%

0%

0%

0%

2.1%

93%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Akutklinik, obs afs modtagelse, nov 2015 − apr 2016

80

7

0 0

0 2

7 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Akutklinik, obs afs modtagelse

119

181

0

100

200

300

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Akutklinik, obs afs modtagelse

53 20

0

11

6

0

6 0

0 0

0 0



piperacillin og enzym−hæmmer gentamicin

benzylpenicillin flucloxacillin

roxithromycin pivampicillin

ciprofloxacin tobramycin

0

50

100

0

20

40

60

80

0

20

40

60

0

20

40

0

10

20

0

10

20

30

0

20

40

60

0

10

20

30

40

50

0

10

20

30

0

20

40

60

0

10

20

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Akutklinik, obs afs modtagelse

120

Akutklinik, observationsafs + lungemed sengeafs

0%

2.3%

16%

0%

4%

3.5%

0.29%

73%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Akutklinik, observationsafs + lungemed sengeafs, nov 2015 − apr 2016

63

13

10 2

0 6

1 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Akutklinik, observationsafs + lungemed sengeafs

121

847

0

500

1000

1500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Akutklinik, observationsafs + lungemed sengeafs

150

133

75

86

64

37

36 25

8

24

0

20






pivampicillin roxithromycin

0

100

200

300

400

0

50

100

150

200

250

0

100

200

300

0

50

100

150

0

50

100

150

0

50

100

150

200

0

20

40

60

80

0

20

40

60

0

50

100

0

20

40

0

50

100

150

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Akutklinik, observationsafs + lungemed sengeafs

122

Akutklinik, Skader

0%

0.87%

10%

0%

0%

0%

0%

89%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Akutklinik, Skader, nov 2015 − apr 2016

90

0

0 0

0 10

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Akutklinik, Skader

123

00

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Akutklinik, Skader

0 0

0 0

0

0

0 0

0 0

0 0


pivmecillinam roxithromycin


doripenem cefepim



0

20

40

60

80

0

20

40

60

0

20

40

60

80

0

10

20

30

40

0

2

4

6

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Akutklinik, Skader

124

Akutklinikken afs MGSAKUT 40 GLO

0%

0%

0%

0%

0%

0%

0%

100%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Akutklinikken afs MGSAKUT 40 GLO, nov 2015 − apr 2016

100

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Akutklinikken afs MGSAKUT 40 GLO

125

00

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Akutklinikken afs MGSAKUT 40 GLO

0 0

0 0

0 0

0 0

0 0

0 0


amoxicillin og enzym−inhibitor benzylpenicillin


cefepim minocyclin



0

10

20

30

0

10

20

30

40

0

5

10

15

0

2

4

6

8

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Akutklinikken afs MGSAKUT 40 GLO

126

C Kardiologisk Sengeafsnit

0%

0.5%

1.5%

0%

0.37%

11%

6.4%

80%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, C Kardiologisk Sengeafsnit, nov 2015 − apr 2016

80

9

4 2

0 2

1 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, C Kardiologisk Sengeafsnit

127

551

0

200

400

600

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, C Kardiologisk Sengeafsnit

127

60

59 40

13

30

22 25

0 6

5 0


phenoxymethylpenicillin cefuroxim



pivampicillin ampicillin

dicloxacillin roxithromycin

0

50

100

150

200

0

50

100

150

200

0

25

50

75

100

0

25

50

75

0

50

100

150

0

20

40

60

0

20

40

60

0

20

40

60

0

30

60

90

120

0

25

50

75

0

10

20

30

40

50

0

10

20

30

40

50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, C Kardiologisk Sengeafsnit

128

Endo og lunge sengeafs. MG33

0.35%

0.53%

8.8%

0.54%

2.9%

7.6%

5%

74%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Endo og lunge sengeafs. MG33, nov 2015 − apr 2016

74

6

9 3

0 8

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Endo og lunge sengeafs. MG33

129

00

300

600

900

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Endo og lunge sengeafs. MG33

0 0

0 0

0 0

0 0

0 0

0 0



clarithromycin ciprofloxacin

cefuroxim amoxicillin


metronidazol ampicillin

0

100

200

300

0

50

100

150

0

50

100

150

200

0

50

100

150

0

25

50

75

0

20

40

60

0

10

20

30

40

50

0

25

50

75

100

0

20

40

60

0

10

20

30

40

50

0

10

20

30

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Endo og lunge sengeafs. MG33

130

Geriatrisk sengeafsnit

0%

0.083%

2.5%

2.5%

3.4%

4.2%

6.5%

81%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Geriatrisk sengeafsnit, nov 2015 − apr 2016

82

5

5 3

0 2

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Geriatrisk sengeafsnit

131

417

0

250

500

750

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Geriatrisk sengeafsnit

107

0

27

0

0 0

0 0

0 3

0 0






benzylpenicillin trimethoprim

0

50

100

150

200

0

50

100

150

0

25

50

75

0

50

100

150

0

50

100

0

40

80

120

0

25

50

75

100

0

20

40

60

0

10

20

30

40

50

0

10

20

30

0

10

20

30

0

10

20

30

40

50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Geriatrisk sengeafsnit

132

HH Akutmodtagelsen

0.5%

0.5%

7.7%

0.7%

2%

3.6%

2.2%

83%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Akutmodtagelsen, nov 2015 − apr 2016

83

4

4 1

0 6

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Akutmodtagelsen

133

11681000

2000

3000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Akutmodtagelsen

287 317

142 100

84

39

36 30

31 21

20

21




benzylpenicillin roxithromycin

ciprofloxacin moxifloxacin

azithromycin dicloxacillin

0

200

400

600

800

0

200

400

600

0

100

200

300

0

50

100

150

200

50

100

150

0

50

100

150

0

25

50

75

100

0

50

100

150

0

50

100

0

25

50

75

0

25

50

75

100

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Akutmodtagelsen

134

HH Barsel

0%

0.55%

2.5%

0%

3.3%

0%

19%

75%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Barsel, nov 2015 − apr 2016

63

20

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Barsel

135

126

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Barsel

27 20

22

0

0 0

0 0

0 0

0 0



metronidazol phenoxymethylpenicillin

erythromycin meropenem


ampicillin azithromycin

0

20

40

60

80

0

20

40

60

80

0

20

40

60

0

10

20

30

40

50

0

10

20

30

0

10

20

30

40

0

25

50

75

100

0

5

10

15

20

0

3

6

9

12

0

5

10

15

0

2

4

6

0.0

2.5

5.0

7.5

10.0

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Barsel

136

HH Børneafd

0%

3%

9.7%

2.1%

8.2%

3.7%

23%

51%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Børneafd, nov 2015 − apr 2016

60

20

3 4

0 5

4 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Børneafd

137

419

200

400

600

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Børneafd

75 73

58 25

10 19

18 16

15

0

10 12


ampicillin amoxicillin

phenoxymethylpenicillin gentamicin


metronidazol pivmecillinam

clarithromycin ceftriaxon

50

100

150

200

50

100

150

50

100

150

0

20

40

60

80

0

30

60

90

0

25

50

75

0

20

40

60

0

10

20

30

40

0

20

40

60

0

20

40

60

0

20

40

60

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Børneafd

138

HH Børneambulatorium

0%

0%

0%

100%

0%

0%

0%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Børneambulatorium, nov 2015 − apr 2016

0 0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Børneambulatorium

139

5

0

10

20

30

40

50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Børneambulatorium

0 0

0 0

0 0

0 0

0 0

0 0

moxifloxacin sulfamethoxazol og trimethoprim

azithromycin vancomycin


cefepim minocyclin



0

10

20

30

40

0

10

20

30

40

50

0

5

10

15

0

3

6

9

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Børneambulatorium

140

HH Børnedagafsnit

0%

0%

0%

0%

13%

0%

0%

87%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Børnedagafsnit, nov 2015 − apr 2016

83

0

0 6

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Børnedagafsnit

141

12

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Børnedagafsnit

5 2

0 0

0 0

0 0

0

0

0 0

amoxicillin phenoxymethylpenicillin

vancomycin sulfamethoxazol og trimethoprim


amoxicillin og enzym−inhibitor trimethoprim

flucloxacillin fosfomycin

doripenem cefepim

0

10

20

30

0

5

10

15

20

25

0

5

10

15

0

2

4

6

0.0

2.5

5.0

7.5

10.0

0.0

2.5

5.0

7.5

10.0

0

1

2

3

4

5

0.0

0.5

1.0

1.5

2.0

2.5

0.0

0.5

1.0

1.5

2.0

2.5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Børnedagafsnit

142

HH Børnemodtagelsen

0%

2.9%

0%

0%

0.95%

0.71%

4.5%

91%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Børnemodtagelsen, nov 2015 − apr 2016

93

0

0 0

0 0

3 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Børnemodtagelsen

143

102

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Børnemodtagelsen

42 20

11 10

4 0

3

0

0 0

0 0



ampicillin pivmecillinam

gentamicin cefuroxim

ceftriaxon dicloxacillin


0

25

50

75

0

20

40

0

10

20

30

40

50

0

10

20

30

40

0

20

40

0

10

20

30

0.0

2.5

5.0

7.5

10.0

0

4

8

12

0.0

2.5

5.0

7.5

10.0

0

5

10

0.0

2.5

5.0

7.5

10.0

0

2

4

6

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Børnemodtagelsen

144

HH Dagkirurgisk afdeling

0%

4.2%

0%

0%

8.3%

0%

29%

59%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Dagkirurgisk afdeling, nov 2015 − apr 2016

60

23

0 0

0 0

5 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Dagkirurgisk afdeling

145

00

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Dagkirurgisk afdeling

0 0

0 0

0 0

0 0

0 0

0 0


metronidazol gentamicin

tobramycin azithromycin


cefepim minocyclin


0

30

60

90

0

10

20

30

40

50

0

5

10

15

20

0

5

10

0

2

4

6

0

1

2

3

4

5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Dagkirurgisk afdeling

146

HH Dagkirurgisk operation

0%

3.6%

7.8%

0%

8.8%

0%

0%

80%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Dagkirurgisk operation, nov 2015 − apr 2016

46

29

0 10

0 10

2 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Dagkirurgisk operation

147

124

0

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Dagkirurgisk operation

45 33

13 10

0 0

0

0

0 0

0 0


metronidazol azithromycin

flucloxacillin gentamicin

tobramycin fosfomycin

doripenem cefepim


0

50

100

0

25

50

75

0

10

20

30

40

50

0

10

20

30

0

5

10

15

20

25

0.0

2.5

5.0

7.5

10.0

0

5

10

15

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Dagkirurgisk operation

148

HH Endokrinologisk amb

0%

0%

0%

0%

0%

0%

0%

100%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Endokrinologisk amb, nov 2015 − apr 2016

100

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Endokrinologisk amb

149

00

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Endokrinologisk amb

0 0

0 0

0 0

0 0

0 0

0 0



cefepim minocyclin




0

10

20

30

0

5

10

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Endokrinologisk amb

150

HH Fertilitetsklinik

0%

0%

0%

0%

0%

0%

100%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Fertilitetsklinik, nov 2015 − apr 2016

0

100

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Fertilitetsklinik

151

00.0

2.5

5.0

7.5

10.0

12.5

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Fertilitetsklinik

0

0

0 0

0 0

0 0

0 0

0 0

cefuroxim fosfomycin

doripenem cefepim



teicoplanin levofloxacin

lymecyclin cefoxitin

0.0

2.5

5.0

7.5

10.0

12.5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Fertilitetsklinik

152

HH Fødeafsnit, voksne

0%

0%

0%

0%

0%

0%

3.4%

97%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Fødeafsnit, voksne, nov 2015 − apr 2016

96

2

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Fødeafsnit, voksne

153

139

100

150

200

250

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Fødeafsnit, voksne

109

2

0

4

0 0

0

0

0 0

0 0



pivmecillinam metronidazol

roxithromycin fosfomycin

doripenem cefepim


0

100

200

0

50

100

150

0

10

20

30

40

0

5

10

15

0

10

20

30

0

5

10

15

0.0

2.5

5.0

7.5

10.0

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Fødeafsnit, voksne

154

HH Gastroentero Endoskopiafs

0%

0%

0%

0%

0%

0%

100%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Gastroentero Endoskopiafs, nov 2015 − apr 2016

0

100

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Gastroentero Endoskopiafs

155

00

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Gastroentero Endoskopiafs

0 0

0 0

0 0

0 0

0 0

0 0



cefepim minocyclin




0.0

2.5

5.0

7.5

10.0

12.5

0

10

20

30

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Gastroentero Endoskopiafs

156

HH Gynækologi, cop-varer

0%

0%

0%

0%

27%

0%

73%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Gynækologi, cop−varer, nov 2015 − apr 2016

0

78

0

22

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Gynækologi, cop−varer

157

127120

160

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Gynækologi, cop−varer

105 30

0 0

0 0

0 0

0 0

0 0



cefepim minocyclin




80

100

120

140

0

20

40

60

80

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Gynækologi, cop−varer

158

HH Gynækologisk amb

0%

0%

57%

0%

0%

0%

0%

43%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Gynækologisk amb, nov 2015 − apr 2016

0 0

0 0

0

60

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Gynækologisk amb

159

10

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Gynækologisk amb

0 0

0 0

0 0

0 0

0 0

0 0

azithromycin doxycyclin



ampicillin sulfamethizol


cefepim minocyclin

0

5

10

15

0.0

2.5

5.0

7.5

10.0

0

5

10

15

20

0.0

2.5

5.0

7.5

10.0

0

5

10

0

5

10

15

0.0

0.5

1.0

1.5

2.0

0

1

2

3

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Gynækologisk amb

160

HH Gynækologisk sengeafs

0%

0%

6.5%

0%

7.8%

0.85%

22%

63%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Gynækologisk sengeafs, nov 2015 − apr 2016

59

24

0 8

0 5

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Gynækologisk sengeafs

161

228

0

100

200

300

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Gynækologisk sengeafs

51 42

33 20

25

0

10 5

3 0

0 0




azithromycin dicloxacillin



0

25

50

75

100

25

50

75

0

25

50

75

100

0

10

20

30

40

50

0

10

20

30

40

50

0

10

20

30

0

10

20

30

0

10

20

30

0

5

10

15

20

0

10

20

30

0

10

20

0

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Gynækologisk sengeafs

162

HH Gynækologisk/Obstetrisk afd

0%

0%

0%

0%

0%

0%

0%

100%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Gynækologisk/Obstetrisk afd, nov 2015 − apr 2016

100

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Gynækologisk/Obstetrisk afd

163

82

0

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Gynækologisk/Obstetrisk afd

30 20

7

0

0 0

0 0

0 0

0 0


ampicillin phenoxymethylpenicillin

benzylpenicillin nitrofurantoin

erythromycin cefuroxim


cefepim minocyclin

0

20

40

60

80

0

25

50

75

0

5

10

15

20

25

0

10

20

30

40

50

0

10

20

30

40

0

5

10

15

20

25

0

5

10

15

20

25

0

5

10

15

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Gynækologisk/Obstetrisk afd

164

HH Hjerte-og lungemed sengeafd

0.67%

0.91%

5%

0.32%

4.4%

11%

7%

71%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Hjerte−og lungemed sengeafd, nov 2015 − apr 2016

64

11

13 5

0 5

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Hjerte−og lungemed sengeafd

165

1655

1000

1500

2000

2500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Hjerte−og lungemed sengeafd

345 236

153 130

119 119

66 62

50

40

46 44





metronidazol meropenem


200

300

400

500

200

300

0

100

200

300

100

200

50

100

150

200

50

100

150

50

100

150

0

100

200

0

25

50

75

100

25

50

75

100

125

0

25

50

75

100

0

30

60

90

120

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Hjerte−og lungemed sengeafd

166

HH Hjerteinsufficiensklinik

0%

0%

21%

0%

0%

0%

0%

79%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Hjerteinsufficiensklinik, nov 2015 − apr 2016

100

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Hjerteinsufficiensklinik

167

15

0

30

60

90

120

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Hjerteinsufficiensklinik

0 0

0 0

0 0

0

0

0 0

0 0



flucloxacillin amoxicillin

pivampicillin fosfomycin

doripenem cefepim


0

20

40

0

10

20

30

0

10

20

30

0

10

20

30

0

5

10

15

20

25

0.0

2.5

5.0

7.5

10.0

0

5

10

15

20

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Hjerteinsufficiensklinik

168

HH Infektionsmedicin

0.61%

0.34%

12%

4.5%

4%

9.3%

11%

59%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Infektionsmedicin, nov 2015 − apr 2016

61

13

11 4

2 6

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Infektionsmedicin

169

1495

1000

1500

2000

2500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Infektionsmedicin

200

124

120 103

109 79

102

62

60 48

48 30





moxifloxacin dicloxacillin

meropenem ampicillin

0

100

200

300

100

200

0

100

200

300

50

100

150

200

100

200

50

100

150

200

0

50

100

150

200

0

50

100

150

200

0

50

100

150

200

0

50

100

150

0

50

100

150

0

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Infektionsmedicin

170

HH Infektionsmedicinsk amb DOBBELTKONTROL Hele kassser

5.4%

0%

18%

69%

2.6%

1.4%

0.97%

2.7%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Infektionsmedicinsk amb DOBBELTKONTROL Hele kassser, nov 2015 − apr 2016

0 0

3 4

67

6

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Infektionsmedicinsk amb DOBBELTKONTROL Hele kassser

171

364

0

500

1000

1500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Infektionsmedicinsk amb DOBBELTKONTROL Hele kassser

250

0

15 0

0

14

0 0

0 0

0 0

sulfamethoxazol og trimethoprim sulfadiazin

azithromycin clarithromycin

moxifloxacin vancomycin

doxycyclin flucloxacillin

ciprofloxacin ceftriaxon

linezolid pivmecillinam

0

400

800

1200

0

100

200

300

400

500

0

50

100

150

0

100

200

300

400

500

0

50

100

150

0

20

40

60

0

50

100

150

0

40

80

120

0

5

10

15

20

0

10

20

0

10

20

30

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Infektionsmedicinsk amb DOBBELTKONTROL Hele kassser

172

HH Intensiv terapi

0%

2.3%

5.6%

0.78%

22%

24%

20%

26%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Intensiv terapi, nov 2015 − apr 2016

18 20

29 23

0

6

0 0





0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Intensiv terapi

173

649

250

500

750

1000

1250

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Intensiv terapi

186 90

97 97

34 34

13 10

7 2

5 5



cefuroxim vancomycin

erythromycin clarithromycin

benzylpenicillin daptomycin

linezolid dicloxacillin

100

200

300

0

100

200

300

0

50

100

150

200

0

100

200

0

30

60

90

20

40

60

0

10

20

30

40

50

0

10

20

30

40

50

0

20

40

60

0

20

40

60

0

10

20

30

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Intensiv terapi

174

HH Intern opvågning

0%

0%

0%

0%

41%

17%

17%

25%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Intern opvågning, nov 2015 − apr 2016

18 19

25 33

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Intern opvågning

175

53

0

50

100

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Intern opvågning

17

10

16

9

0 0

0 0

0 0

0 0

metronidazol cefuroxim


meropenem vancomycin

ampicillin gentamicin

tobramycin sulfamethizol


0

10

20

30

40

0

10

20

30

40

50

0

5

10

15

20

25

0

10

20

0

1

2

3

4

5

0.0

0.5

1.0

1.5

0.00

0.25

0.50

0.75

1.00

0

1

2

3

4

5

0

1

2

3

0

1

2

3

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Intern opvågning

176

HH Kardiologi

0.29%

0.24%

4.7%

0.84%

2.8%

5.7%

3.4%

82%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Kardiologi, nov 2015 − apr 2016

71

10

9 4

0 2

1 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Kardiologi

177

799

500

750

1000

1250

1500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Kardiologi

150 127

104 99

69 52

33 38

12 10

13 10





ampicillin dicloxacillin


100

200

300

400

100

200

50

100

150

200

50

100

150

200

0

50

100

150

0

50

100

150

200

0

50

100

150

0

40

80

120

0

50

100

150

0

20

40

60

0

10

20

30

40

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Kardiologi

178

HH Kir Gast. 5-døgnsafs

0%

0%

2.6%

0%

22%

38%

10%

27%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Kir Gast. 5−døgnsafs, nov 2015 − apr 2016

26 20

29 20

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Kir Gast. 5−døgnsafs

179

48

0

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Kir Gast. 5−døgnsafs

15 10

8

0

0 0

0 0

0 0

0 0




dicloxacillin amoxicillin


azithromycin meropenem

0

20

40

60

0

10

20

30

40

0

10

20

30

40

0

10

20

30

0

10

20

30

0

3

6

9

0.0

2.5

5.0

7.5

10.0

0

5

10

15

20

0

5

10

15

20

0

5

10

15

0

1

2

3

4

5

0.0

2.5

5.0

7.5

10.0

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Kir Gast. 5−døgnsafs

180

HH Kir gastro. cop-varer

0%

2.7%

0%

0%

50%

2.7%

42%

1.7%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Kir gastro. cop−varer, nov 2015 − apr 2016

1

45

0

49

0 0

2 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Kir gastro. cop−varer

181

239

200

300

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Kir gastro. cop−varer

120

114

0 3

0 0

0 0

0 0

0 0



tobramycin gentamicin


cefepim minocyclin


100

200

300

75

100

125

150

0

5

10

15

20

25

0

5

10

15

0

5

10

15

20

0

5

10

15

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Kir gastro. cop−varer

182

HH Kir gastroent. sengeafs

0.24%

2.3%

2.3%

0.5%

23%

13%

10%

48%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Kir gastroent. sengeafs, nov 2015 − apr 2016

35

19

17 24

0 2

1 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Kir gastroent. sengeafs

183

2130

1000

2000

3000

4000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Kir gastroent. sengeafs

450

327

354 273

201 74

60 55

38 28

25 20




amoxicillin og enzym−inhibitor meropenem

vancomycin clarithromycin

flucloxacillin pivampicillin

200

400

600

200

400

600

800

200

400

600

200

400

600

200

400

600

0

100

200

50

100

150

200

0

50

100

150

0

50

100

150

0

50

100

150

0

40

80

120

0

30

60

90

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Kir gastroent. sengeafs

184

HH Klinisk mikrobiologi

5.8%

0%

87%

4.9%

0%

2.7%

0%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Klinisk mikrobiologi, nov 2015 − apr 2016

0 0

0 0

15

83

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Klinisk mikrobiologi

185

181

0

200

400

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Klinisk mikrobiologi

154

12

0 0

0 0

0

0

0 0

0 0

clindamycin sulfamethoxazol og trimethoprim

doxycyclin moxifloxacin

trimethoprim fusidinsyre

clarithromycin fosfomycin

doripenem cefepim


0

200

400

0

50

100

150

0

20

40

60

80

0

10

20

0

20

40

60

0

5

10

15

20

0

5

10

15

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Klinisk mikrobiologi

186

HH Lungemedicinsk dagafsnit

0%

80%

0%

6.5%

12%

0%

0%

1.9%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Lungemedicinsk dagafsnit, nov 2015 − apr 2016

0 0

0 0

18

0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Lungemedicinsk dagafsnit

187

25

0

100

200

300

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Lungemedicinsk dagafsnit

0 0

0 0

0 0

0 0

0 0

0 0

tobramycin sulfamethoxazol og trimethoprim

ampicillin colistin

azithromycin amoxicillin og enzym−inhibitor


cefepim minocyclin


0

50

100

150

200

0

20

40

60

0

10

20

30

40

0

25

50

75

0

10

20

30

40

50

0

5

10

15

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Lungemedicinsk dagafsnit

188

HH Neonatalafsnit

0%

6.8%

0%

0%

4.1%

0%

14%

75%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Neonatalafsnit, nov 2015 − apr 2016

70

16

0 2

0 0

9 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Neonatalafsnit

189

48

20

40

60

80

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Neonatalafsnit

31 4

4

2

0 0

0 0

0 0

0 0


gentamicin meropenem


metronidazol ceftriaxon

vancomycin cefotaxim


0

20

40

60

0.0

2.5

5.0

7.5

1

2

3

4

5

6

0

2

4

6

0

5

10

15

0

2

4

6

0

2

4

6

0

1

2

3

4

5

0

1

2

3

0.0

0.5

1.0

1.5

2.0

2.5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Neonatalafsnit

190

HH Obstetrik Barsel 412

0%

2.9%

2.9%

0%

6.8%

0%

15%

72%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Obstetrik Barsel 412, nov 2015 − apr 2016

75

10

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Obstetrik Barsel 412

191

00

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Obstetrik Barsel 412

0 0

0 0

0 0

0 0

0 0

0 0




dicloxacillin azithromycin

roxithromycin gentamicin

meropenem benzylpenicillin

0

20

40

0

20

40

60

0

5

10

15

20

25

0

5

10

15

20

0

5

10

15

20

25

0.0

2.5

5.0

7.5

10.0

0

5

10

15

0

1

2

3

4

5

0.0

2.5

5.0

7.5

10.0

0.0

2.5

5.0

7.5

10.0

0.0

2.5

5.0

7.5

10.0

0

2

4

6

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Obstetrik Barsel 412

192

HH Obstetrik svangre sengeafs

0%

0%

2.3%

0.39%

1.7%

0%

3.9%

92%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Obstetrik svangre sengeafs, nov 2015 − apr 2016

88

7

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Obstetrik svangre sengeafs

193

103100

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Obstetrik svangre sengeafs

40

0

5 5

0 0

0 0

0 0

0 0



ampicillin nitrofurantoin


erythromycin metronidazol

roxithromycin spiramycin

0

50

100

150

0

25

50

75

100

0

10

20

30

40

50

0

10

20

30

40

0

5

10

15

20

0

5

10

15

20

25

0

10

20

30

40

50

0

5

10

15

20

25

0

5

10

15

20

25

0

10

20

30

0

5

10

15

20

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Obstetrik svangre sengeafs

194

HH Ortopædkirurgi 312

0.14%

0%

0.068%

0.89%

2.8%

4.4%

7%

85%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Ortopædkirurgi 312, nov 2015 − apr 2016

77

11

5 3

0 0

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Ortopædkirurgi 312

195

902

600

900

1200

1500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Ortopædkirurgi 312

237 112

92 71

87 54

54 30

18 0

7 0

pivmecillinam flucloxacillin




benzylpenicillin pivampicillin


200

300

400

0

100

200

300

50

100

150

200

0

100

200

40

80

120

160

0

50

100

150

0

40

80

120

0

25

50

75

0

30

60

90

0

20

40

60

0

10

20

30

40

50

0

30

60

90

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Ortopædkirurgi 312

196

HH Ortopædkirurgi 315

0%

0%

2.9%

1.5%

5.7%

2.1%

19%

69%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Ortopædkirurgi 315, nov 2015 − apr 2016

69

18

4 3

0 2

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Ortopædkirurgi 315

197

1104

500

1000

1500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Ortopædkirurgi 315

200 172

133 112

99 41

31 34

24 17

0

16





pivampicillin clindamycin

ampicillin vancomycin

0

200

400

600

0

100

200

300

0

200

400

600

100

200

0

100

200

300

0

25

50

75

100

125

0

25

50

75

100

125

0

20

40

60

80

0

50

100

150

0

50

100

150

200

250

0

50

100

150

0

20

40

60

80

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Ortopædkirurgi 315

198

HH Ortopædkirurgi amb

0%

0%

0%

0%

35%

0%

0%

65%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Ortopædkirurgi amb, nov 2015 − apr 2016

100

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Ortopædkirurgi amb

199

00

20

40

60

80

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Ortopædkirurgi amb

0 0

0 0

0 0

0 0

0 0

0 0

flucloxacillin sulfamethoxazol og trimethoprim

pivampicillin phenoxymethylpenicillin

pivmecillinam linezolid


cefepim minocyclin


0

5

10

15

20

25

0

10

20

30

40

50

0

5

10

15

0

5

10

15

20

0

5

10

0

2

4

6

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Ortopædkirurgi amb

200

HH Ortopædkirurgi, cop-varer

0%

7.9%

0%

0%

0%

0%

12%

81%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Ortopædkirurgi, cop−varer, nov 2015 − apr 2016

77

16

0 0

0 0

7 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Ortopædkirurgi, cop−varer

201

322

100

200

300

400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Ortopædkirurgi, cop−varer

281

55

0 0

0 0

0 0

0 0

0 0


gentamicin tobramycin


vancomycin linezolid


cefepim minocyclin

0

100

200

300

400

0

100

200

300

0

20

40

0

10

20

30

0

2

4

6

8

0

5

10

15

0

2

4

6

0.00

0.25

0.50

0.75

1.00

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Ortopædkirurgi, cop−varer

202

HH Palliativ Enhed amb/seng

1.8%

0%

5.4%

0%

7.4%

11%

7.1%

68%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, HH Palliativ Enhed amb/seng, nov 2015 − apr 2016

58

8

7 6

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, HH Palliativ Enhed amb/seng

203

87

50

100

150

200

250

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, HH Palliativ Enhed amb/seng

13

15

9

0

0

6

0 0

0 0

0 0



flucloxacillin ciprofloxacin


doxycyclin nitrofurantoin

azithromycin pivampicillin

0

20

40

60

0

10

20

30

0

10

20

0

20

40

60

0

10

20

30

40

50

0

5

10

15

20

0

10

20

30

40

50

0

10

20

30

0

10

20

30

0

5

10

15

20

25

0

5

10

15

20

0

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, HH Palliativ Enhed amb/seng

204

Kardiologisk sengeafs MG31 GLO

0%

0.77%

8.6%

1.2%

4.4%

7.3%

8.3%

69%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Kardiologisk sengeafs MG31 GLO, nov 2015 − apr 2016

73

9

8 1

0 6

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Kardiologisk sengeafs MG31 GLO

205

00

200

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Kardiologisk sengeafs MG31 GLO

0 0

0 0

0 0

0 0

0 0

0 0




benzylpenicillin ciprofloxacin


dicloxacillin flucloxacillin

0

50

100

0

20

40

60

0

25

50

75

0

20

40

60

0

20

40

60

0

10

20

30

40

50

0

10

20

30

40

0

10

20

30

0

10

20

30

40

50

0

10

20

30

0

10

20

30

0

5

10

15

20

25

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Kardiologisk sengeafs MG31 GLO

206

Kardiologisk Sengeafsnit C

0%

0%

5%

0%

1.2%

4.8%

3.9%

85%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Kardiologisk Sengeafsnit C, nov 2015 − apr 2016

86

3

3 1

0 5

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Kardiologisk Sengeafsnit C

207

00

200

400

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Kardiologisk Sengeafsnit C

0 0

0 0

0 0

0 0

0 0

0 0


piperacillin og enzym−hæmmer benzylpenicillin



ciprofloxacin roxithromycin


0

50

100

150

0

50

100

150

0

25

50

75

0

50

100

150

0

40

80

120

0

25

50

75

0

20

40

60

0

10

20

30

40

50

0

10

20

30

40

0

10

20

30

40

0

10

20

30

40

0

5

10

15

20

25

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Kardiologisk Sengeafsnit C

208

Lungemedicinsk afsnit

0%

0.6%

6.6%

2.3%

6.7%

9.7%

1.1%

73%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Lungemedicinsk afsnit, nov 2015 − apr 2016

72

8

9 3

0 9

1 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Lungemedicinsk afsnit

209

00

500

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Lungemedicinsk afsnit

0 0

0 0

0 0

0 0

0 0

0 0




cefuroxim clarithromycin


ampicillin meropenem

0

100

200

300

400

0

50

100

150

200

0

100

200

300

0

50

100

150

0

50

100

150

0

25

50

75

100

0

30

60

90

0

20

40

60

80

0

20

40

60

80

0

20

40

60

0

25

50

75

100

125

0

20

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Lungemedicinsk afsnit

210

Lungemedicinsk Sengeafsnit

0.54%

0.79%

11%

0.45%

2.7%

5.6%

6.2%

72%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Lungemedicinsk Sengeafsnit, nov 2015 − apr 2016

74

7

6 2

0 8

1 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Lungemedicinsk Sengeafsnit

211

00

400

800

1200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Lungemedicinsk Sengeafsnit

0 0

0 0

0 0

0 0

0 0

0 0

pivampicillin piperacillin og enzym−hæmmer


phenoxymethylpenicillin clarithromycin


roxithromycin flucloxacillin


0

100

200

300

0

50

100

150

200

0

50

100

150

200

0

50

100

150

200

0

25

50

75

100

0

50

100

150

0

20

40

60

0

20

40

0

20

40

60

80

0

10

20

30

40

50

0

20

40

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Lungemedicinsk Sengeafsnit

212

Med. geri. sengeafs. MG42 GLO

0%

0.23%

4.6%

0.2%

3.3%

7.9%

5.8%

78%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Med. geri. sengeafs. MG42 GLO, nov 2015 − apr 2016

78

6

7 2

0 2

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Med. geri. sengeafs. MG42 GLO

213

00

200

400

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Med. geri. sengeafs. MG42 GLO

0 0

0 0

0 0

0 0

0 0

0 0



ciprofloxacin pivampicillin




0

50

100

150

0

50

100

150

0

20

40

60

0

25

50

75

100

0

25

50

75

100

0

25

50

75

0

10

20

30

40

50

0

10

20

30

40

0

10

20

30

0

10

20

30

0

10

20

30

40

0

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Med. geri. sengeafs. MG42 GLO

214

Med. kadio. sengeafs. MG32 GLO

0%

0.7%

8.3%

0.54%

4.6%

11%

8.5%

66%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Med. kadio. sengeafs. MG32 GLO, nov 2015 − apr 2016

67

9

11 4

0 7

1 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Med. kadio. sengeafs. MG32 GLO

215

00

300

600

900

1200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Med. kadio. sengeafs. MG32 GLO

0 0

0 0

0 0

0 0

0 0

0 0




clarithromycin cefuroxim

benzylpenicillin pivampicillin


0

50

100

150

0

50

100

150

0

50

100

150

200

0

50

100

0

50

100

150

200

0

30

60

90

0

25

50

75

100

0

20

40

60

0

20

40

60

80

0

20

40

60

0

20

40

60

0

20

40

60

80

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Med. kadio. sengeafs. MG32 GLO

216

Medicinsk dagafsnit

0%

4.7%

4.2%

0%

0%

0%

21%

70%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Medicinsk dagafsnit, nov 2015 − apr 2016

91

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Medicinsk dagafsnit

217

00

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Medicinsk dagafsnit

0 0

0 0

0 0

0 0

0 0

0 0


benzylpenicillin gentamicin

ceftriaxon ampicillin



cefepim minocyclin

0

3

6

9

0.0

2.5

5.0

7.5

10.0

0

5

10

0

5

10

0.0

2.5

5.0

7.5

10.0

0.0

2.5

5.0

7.5

10.0

0

1

2

3

4

5

0

1

2

3

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Medicinsk dagafsnit

218

Medicinsk modtage afs MGIMOD

0%

3.9%

9.6%

1.6%

1.9%

2.5%

5.3%

75%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Medicinsk modtage afs MGIMOD, nov 2015 − apr 2016

74

6

2 1

0 7

5 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Medicinsk modtage afs MGIMOD

219

00

100

200

300

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Medicinsk modtage afs MGIMOD

0 0

0 0

0 0

0 0

0 0

0 0



clarithromycin gentamicin



ciprofloxacin roxithromycin

0

25

50

75

0

25

50

75

0

10

20

30

0

10

20

30

0

10

20

30

0

10

20

0

10

20

0

5

10

15

20

0

5

10

15

0

5

10

15

20

25

0

5

10

15

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Medicinsk modtage afs MGIMOD

220

Observationsafsnit

0.23%

0.16%

16%

1.2%

2.7%

6.5%

4.9%

68%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Observationsafsnit, nov 2015 − apr 2016

71

5

8 3

0

16

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Observationsafsnit

221

00

500

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Observationsafsnit

0 0

0 0

0 0

0 0

0 0

0 0





flucloxacillin roxithromycin

dicloxacillin azithromycin

0

50

100

150

200

0

50

100

0

50

100

150

200

250

0

50

100

150

200

0

50

100

150

0

25

50

75

0

20

40

60

0

10

20

30

0

25

50

75

100

0

10

20

30

40

0

10

20

30

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Observationsafsnit

222

Observationsafsnit, modtagelse

0%

1%

7.3%

0%

0%

2.5%

6.7%

83%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler HH, Observationsafsnit, modtagelse, nov 2015 − apr 2016

82

3

0 0

0 8

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, HH, Observationsafsnit, modtagelse

223

00

100

200

300

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, HH, Observationsafsnit, modtagelse

0 0

0 0

0 0

0 0

0 0

0 0


piperacillin og enzym−hæmmer roxithromycin




ceftriaxon ampicillin

0

25

50

75

0

20

40

60

0

10

20

0

5

10

15

20

0

10

20

30

0

10

20

30

0

5

10

15

20

0

5

10

15

0

5

10

15

20

25

0

5

10

15

20

0.0

2.5

5.0

7.5

10.0

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, HH, Observationsafsnit, modtagelse

224

Nordsjællands Hospital

1.8%

1.4%

7.9%

1.1%

6.4%

4%

10%

67%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, nov 2015 − apr 2016

65

14

5 7

1 6

1 1





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, Nordsjællands Hospital

225

16893

15000

17500

20000

22500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO

2313 1435

1536 1383

1347 914

865 883

787

628

708 602



piperacillin og enzym−hæmmer benzylpenicillin




2100

2400

2700

3000

1000

1500

2000

2500

3000

1200

1500

1800

2100

1000

1500

2000

2500

500

1000

1500

2000

2500

750

1000

1250

1500

600

800

1000

1200

700

800

900

1000

1100

500

1000

500

1000

1500

2000

400

600

800

1000

500

750

1000

1250

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO

226

Akut gyn/Bækkenbundsklinikken

0%

0%

100%

0%

0%

0%

0%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Akut gyn/Bækkenbundsklinikken, nov 2015 − apr 2016

0 0

0 0

0

100

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Akut gyn/Bækkenbundsklinikken

227

00

5

10

15

20

25

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Akut gyn/Bækkenbundsklinikken

0 0

0 0

0 0

0 0

0 0

0 0

flucloxacillin azithromycin


cefepim minocyclin




0

5

10

15

20

25

0.0

2.5

5.0

7.5

10.0

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Akut gyn/Bækkenbundsklinikken

228

Akut modt for gravide 0131 HI

0%

0.41%

7.3%

0%

1.1%

0%

12%

80%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Akut modt for gravide 0131 HI, nov 2015 − apr 2016

84

10

0 0

0 1

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Akut modt for gravide 0131 HI

229

113

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Akut modt for gravide 0131 HI

47 20

23

10

2

0

0 0

0 0

0 0




nitrofurantoin azithromycin

roxithromycin clarithromycin

flucloxacillin clindamycin

0

30

60

90

0

20

40

10

20

30

40

0

10

20

30

0

2

4

6

0

10

20

30

40

50

0

5

10

15

20

25

0

5

10

15

20

0.0

2.5

5.0

7.5

10.0

0

5

10

0

5

10

15

20

25

0

3

6

9

12

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Akut modt for gravide 0131 HI

230

Akutafdelingen BASE 1

0%

2.6%

5%

0%

3.1%

0.88%

7.7%

81%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Akutafdelingen BASE 1, nov 2015 − apr 2016

73

11

0 5

0 4

3 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Akutafdelingen BASE 1

231

278

100

200

300

400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Akutafdelingen BASE 1

67

40

18

22

30 17

15

0

7

0

5

6





gentamicin roxithromycin


0

50

100

0

50

100

150

0

20

40

60

0

20

40

0

25

50

75

10

20

30

40

0

10

20

30

0

20

40

60

0

5

10

15

20

0

20

40

60

0

10

20

0

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Akutafdelingen BASE 1

232


0%

7.3%

14%

0.81%

2.5%

3%

6.3%

66%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%


66

11

3 3

0

11

4 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned


233

796

600

900

1200

1500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD


160

79

64 57

45 42

45 30

30 28

28 18



amoxicillin og enzym−inhibitor clarithromycin

benzylpenicillin amoxicillin

gentamicin ciprofloxacin


100

150

200

0

50

100

150

200

50

100

150

40

80

120

160

0

50

100

150

200

250

0

50

100

150

25

50

75

100

125

0

50

100

150

0

25

50

75

100

20

40

60

0

25

50

75

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D


234


0%

0.64%

3.8%

0%

0.43%

0%

2.7%

92%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%


89

2

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned


235

259

100

200

300

400

500

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD


99 50

40 30

30

10

0 6

8

0

0 2




roxithromycin piperacillin og enzym−hæmmer


gentamicin ampicillin

0

100

200

0

40

80

120

0

50

100

0

20

40

60

0

20

40

60

0

10

20

30

40

0

10

20

30

40

0

10

20

30

0

5

10

15

0

10

20

30

0

5

10

15

0

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D


236

Akutklinik skadestueafs FS

0%

6.7%

7%

0.44%

1.1%

2.3%

3.4%

79%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Akutklinik skadestueafs FS, nov 2015 − apr 2016

77

4

3 0

0 4

6 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Akutklinik skadestueafs FS

237

367

200

400

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Akutklinik skadestueafs FS

93

59

38 17

17

0

11 10

9 9

0

5


amoxicillin og enzym−inhibitor benzylpenicillin

gentamicin flucloxacillin


ampicillin ciprofloxacin

roxithromycin dicloxacillin

50

100

150

0

50

100

150

200

0

25

50

75

100

0

20

40

60

0

10

20

30

40

50

0

20

40

60

0

20

40

0

10

20

30

40

0

10

20

30

40

0

10

20

30

40

50

0

10

20

30

40

50

0

10

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Akutklinik skadestueafs FS

238

Akutklinik, sengeafs FS

0%

0.67%

19%

0.3%

0%

0.7%

0.25%

79%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Akutklinik, sengeafs FS, nov 2015 − apr 2016

79

0

0 0

0

15

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Akutklinik, sengeafs FS

239

290

0

200

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Akutklinik, sengeafs FS

109 60

20 15

25

0

0 2

0 0

0 0


roxithromycin amoxicillin og enzym−inhibitor


gentamicin benzylpenicillin


ampicillin sulfamethizol

0

50

100

150

0

50

100

0

50

100

0

25

50

75

100

0

10

20

30

40

50

0

5

10

15

20

25

0

5

10

15

20

0

5

10

15

0

10

20

0

5

10

15

0.0

2.5

5.0

7.5

10.0

0.0

2.5

5.0

7.5

10.0

12.5

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Akutklinik, sengeafs FS

240

Akutklinik, sygepl-afs SH

0%

0%

6.6%

0.18%

0%

0%

0%

93%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Akutklinik, sygepl−afs SH, nov 2015 − apr 2016

93

0

0 0

0 7

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Akutklinik, sygepl−afs SH

241

238

100

200

300

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Akutklinik, sygepl−afs SH

132 40

30 20

25

0

0 0

0

0

0 0


amoxicillin og enzym−inhibitor roxithromycin


erythromycin sulfamethizol


doripenem cefepim

100

150

200

0

25

50

75

100

0

20

40

60

0

20

40

60

0

10

20

30

40

50

0

3

6

9

12

0

5

10

15

20

25

0

2

4

6

0

1

2

3

4

5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Akutklinik, sygepl−afs SH

242

Anæstesi/OP afs 0133 HI

0%

100%

0%

0%

0%

0%

0%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Anæstesi/OP afs 0133 HI, nov 2015 − apr 2016

0 0

0 0

0 0

100

0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Anæstesi/OP afs 0133 HI

243

10.0

2.5

5.0

7.5

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Anæstesi/OP afs 0133 HI

1

0

0 0

0 0

0 0

0 0

0 0


doripenem cefepim





0.0

2.5

5.0

7.5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Anæstesi/OP afs 0133 HI

244

Anæstesiologisk afd HI

0%

8.8%

0%

0%

26%

0%

37%

28%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Anæstesiologisk afd HI, nov 2015 − apr 2016

22

42

0

26

0 0

9

0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Anæstesiologisk afd HI

245

410400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Anæstesiologisk afd HI

163 107

54 36

26

0

0 0

0 0

0 0


dicloxacillin gentamicin

piperacillin og enzym−hæmmer tobramycin

cloxacillin benzylpenicillin


cefepim minocyclin

150

200

250

300

90

120

150

0

30

60

90

120

0

20

40

60

0

10

20

30

40

50

0

10

20

30

40

50

0

10

20

30

40

50

0

2

4

6

8

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Anæstesiologisk afd HI

246

Barselsafs 1 sengeafs 1543 HI

0%

0.63%

0.95%

0%

1.3%

0%

10%

87%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Barselsafs 1 sengeafs 1543 HI, nov 2015 − apr 2016

84

12

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Barselsafs 1 sengeafs 1543 HI

247

71

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Barselsafs 1 sengeafs 1543 HI

14

0

9

0

0

8

0 0

0 0

0 0




metronidazol amoxicillin og enzym−inhibitor


cloxacillin piperacillin og enzym−hæmmer

0

20

40

0

20

40

60

0

10

20

30

0

20

40

0

10

20

30

40

0

5

10

15

20

0

5

10

15

0

5

10

15

0

5

10

15

20

0

2

4

6

8

0.0

2.5

5.0

7.5

10.0

0.0

2.5

5.0

7.5

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Barselsafs 1 sengeafs 1543 HI

248

Barselsafsnit 2 senge. G 0142 HI

0%

0%

0%

0%

3.3%

0%

22%

75%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Barselsafsnit 2 senge. G 0142 HI, nov 2015 − apr 2016

69

31

0 0

0 0

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Barselsafsnit 2 senge. G 0142 HI

249

67

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Barselsafsnit 2 senge. G 0142 HI

20 12

7 0

5

0

0 0

0 0

0 0




benzylpenicillin cefalexin



10

20

30

40

0

10

20

30

40

50

0

20

40

60

0

20

40

60

0

5

10

15

20

0

10

20

30

40

0

5

10

0

5

10

15

0

5

10

15

0

1

2

3

4

0

5

10

15

0

2

4

6

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Barselsafsnit 2 senge. G 0142 HI

250

Børne og unge akutmod 1521 HI

0%

3.1%

0%

0%

0.65%

1.9%

3.3%

91%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Børne og unge akutmod 1521 HI, nov 2015 − apr 2016

92

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Børne og unge akutmod 1521 HI

251

85

0

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Børne og unge akutmod 1521 HI

25 18

12

0

3

0

0 0

1

0

0 0


amoxicillin pivmecillinam

ampicillin pivampicillin

gentamicin vancomycin

dicloxacillin ceftriaxon


0

20

40

0

10

20

30

40

0

10

20

30

0

30

60

90

0.0

2.5

5.0

7.5

0

5

10

15

0.0

2.5

5.0

7.5

10.0

0

5

10

15

0

1

2

3

4

5

0

5

10

15

0.0

2.5

5.0

7.5

10.0

0

1

2

3

4

5

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Børne og unge akutmod 1521 HI

252

Børne og unge sengeafs 0632 HI

0%

1.6%

31%

0%

3.1%

6.3%

2.5%

55%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Børne og unge sengeafs 0632 HI, nov 2015 − apr 2016

66

6

0 3

0

17

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Børne og unge sengeafs 0632 HI

253

94

0

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Børne og unge sengeafs 0632 HI

12 10

8

10

2 3

2 0

2 0

0 1

phenoxymethylpenicillin azithromycin



flucloxacillin amoxicillin og enzym−inhibitor


clarithromycin piperacillin og enzym−hæmmer

0

10

20

30

40

50

0

10

20

30

40

0

20

40

60

0

10

20

30

0

10

20

30

0

5

10

15

20

0

10

20

30

0

10

20

30

0

5

10

15

0

5

10

15

20

0

10

20

30

0

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Børne og unge sengeafs 0632 HI

254


0%

3.4%

16%

0.13%

1%

2.1%

10%

67%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%


74

8

0 0

0 11

3 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned


255

292

100

200

300

400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD


43 30

28

26

22

0

15

14

11 10

10

5

ampicillin amoxicillin





gentamicin ceftriaxon

25

50

75

0

25

50

75

100

0

40

80

120

0

20

40

60

0

20

40

60

80

0

50

100

0

10

20

30

0

20

40

60

0

10

20

30

40

0

10

20

30

40

0

10

20

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D


256


0%

3.7%

0%

0%

2%

0%

0.5%

94%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%


92

0

0 0

0 0

4 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned


257

25

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD


19

0

1 0

0 0

0 0

0

0

0 0


gentamicin pivampicillin

cefotaxim meropenem


fusidinsyre fosfomycin

doripenem cefepim

10

20

30

40

50

0.0

2.5

5.0

7.5

10.0

0

2

4

6

0

5

10

15

20

0

2

4

6

0

1

2

3

4

5

0.0

2.5

5.0

7.5

10.0

0.0

0.5

1.0

1.5

2.0

2.5

0

1

2

3

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D


258

Dag. kir. afs. 0162 HI

0%

0%

19%

0%

13%

0%

62%

5.5%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Dag. kir. afs. 0162 HI, nov 2015 − apr 2016

0

69

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Dag. kir. afs. 0162 HI

259

11

0

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Dag. kir. afs. 0162 HI

5

0

0 0

0 0

0 0

0 0

0 0

cefalexin azithromycin


piperacillin og enzym−hæmmer fusidinsyre


cefepim minocyclin


0

5

10

15

20

25

0

5

10

15

0

5

10

15

0.0

2.5

5.0

7.5

10.0

0

1

2

0

2

4

6

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Dag. kir. afs. 0162 HI

260

Dagkirurgisk afs 0153 HI

0%

0%

0%

0%

40%

0%

53%

7.3%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Dagkirurgisk afs 0153 HI, nov 2015 − apr 2016

0

55

0

40

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Dagkirurgisk afs 0153 HI

261

28

0

20

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Dagkirurgisk afs 0153 HI

15 13

0 0

0

0

0 0

0 0

0 0




doripenem cefepim



0

10

20

30

0

10

20

30

0

3

6

9

0

2

4

6

0

1

2

3

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Dagkirurgisk afs 0153 HI

262

Gyn amb-afs G 0211 HI

0%

0%

100%

0%

0%

0%

0%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Gyn amb−afs G 0211 HI, nov 2015 − apr 2016

0 0

0 0

0

100

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Gyn amb−afs G 0211 HI

263

00

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Gyn amb−afs G 0211 HI

0

0

0 0

0 0

0 0

0 0

0 0

azithromycin fosfomycin

doripenem cefepim





0

5

10

15

20

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Gyn amb−afs G 0211 HI

264

Gyn sengeafs G 0121 HI

4.3%

1.7%

9.8%

1.1%

11%

2.8%

12%

57%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Gyn sengeafs G 0121 HI, nov 2015 − apr 2016

55

16

0 9

0 7

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Gyn sengeafs G 0121 HI

265

180

100

200

300

400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Gyn sengeafs G 0121 HI

47 34

28 17

12 5

0 0

0 0

2 0



azithromycin piperacillin og enzym−hæmmer

phenoxymethylpenicillin doxycyclin

flucloxacillin amoxicillin og enzym−inhibitor

ampicillin ciprofloxacin

0

30

60

90

0

20

40

60

0

25

50

75

0

20

40

0

10

20

30

40

0

5

10

15

20

0

20

40

0

5

10

15

20

0

5

10

15

20

25

0

10

20

30

0

5

10

15

20

25

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Gyn sengeafs G 0121 HI

266

HI Onkologisk senge. E 0861 HI

0%

0.77%

6.7%

0.2%

8.2%

4.8%

15%

65%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, HI Onkologisk senge. E 0861 HI, nov 2015 − apr 2016

63

16

3 7

1 1

1 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, HI Onkologisk senge. E 0861 HI

267

511

300

400

500

600

700

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, HI Onkologisk senge. E 0861 HI

82 73

67

40

25 30

16 20

12 2

10 5



meropenem phenoxymethylpenicillin


flucloxacillin clarithromycin


0

50

100

150

200

50

100

0

50

100

150

50

100

150

0

20

40

60

80

0

20

40

60

80

0

20

40

60

0

20

40

0

20

40

60

0

20

40

60

0

20

40

60

0

25

50

75

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, HI Onkologisk senge. E 0861 HI

268

Håndkirurgisk klinik 0823 HI

0%

0%

0%

0%

0%

0%

4.8%

95%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Håndkirurgisk klinik 0823 HI, nov 2015 − apr 2016

100

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Håndkirurgisk klinik 0823 HI

269

11

0

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Håndkirurgisk klinik 0823 HI

10

0

0 0

0

0

0 0

0 0

0 0

dicloxacillin flucloxacillin

cefuroxim cloxacillin

benzylpenicillin fosfomycin

doripenem cefepim



0

5

10

15

20

25

0

5

10

15

20

25

0

1

2

3

4

5

0

5

10

15

0

1

2

3

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Håndkirurgisk klinik 0823 HI

270

Infektiomed sengafs 0651 HI

2%

0.29%

12%

2.2%

4.5%

5.8%

10%

63%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Infektiomed sengafs 0651 HI, nov 2015 − apr 2016

60

14

5 4

2 8

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Infektiomed sengafs 0651 HI

271

1012

0

500

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Infektiomed sengafs 0651 HI

97 76

35

63

74 61

45 35

52 44

38 25


amoxicillin benzylpenicillin


amoxicillin og enzym−inhibitor dicloxacillin

clarithromycin ciprofloxacin


0

50

100

150

200

0

50

100

150

200

0

100

200

300

0

50

100

150

0

50

100

0

50

100

0

50

100

150

200

250

0

50

100

150

0

50

100

0

50

100

0

40

80

120

0

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Infektiomed sengafs 0651 HI

272

Infektiomed sengafs 0651Nord

2.7%

0.15%

10%

0.067%

2.8%

4.5%

17%

62%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Infektiomed sengafs 0651Nord, nov 2015 − apr 2016

57

20

4 4

0 8

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Infektiomed sengafs 0651Nord

273

589

400

500

600

700

800

900

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Infektiomed sengafs 0651Nord

58 53

54 43

40 39

20

30

30 30

25 20



phenoxymethylpenicillin meropenem

amoxicillin dicloxacillin

clarithromycin amoxicillin og enzym−inhibitor


50

100

50

100

150

0

30

60

90

120

25

50

75

100

0

25

50

75

100

25

50

75

100

0

50

100

150

200

250

0

25

50

75

0

20

40

60

0

20

40

60

0

25

50

75

100

0

25

50

75

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Infektiomed sengafs 0651Nord

274

Intensiv afd 0531 HI

0%

0%

7.3%

0.9%

21%

9.7%

29%

33%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Intensiv afd 0531 HI, nov 2015 − apr 2016

27 32

13

22

0 5

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Intensiv afd 0531 HI

275

427

300

400

500

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Intensiv afd 0531 HI

75

64

60 50

49 20

9 12

0 3

0 0




benzylpenicillin vancomycin


dicloxacillin linezolid

0

50

100

40

80

120

160

50

75

100

125

0

25

50

75

100

0

25

50

75

100

10

20

30

40

0

10

20

30

40

0

20

40

60

0

100

200

0

10

20

30

0

10

20

30

40

0

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Intensiv afd 0531 HI

276

Intermediært sengeafs 0633 HI

0%

0.39%

9.5%

0.088%

20%

9.2%

24%

37%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Intermediært sengeafs 0633 HI, nov 2015 − apr 2016

33 29

9

21

0

9

0 0





0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Intermediært sengeafs 0633 HI

277

529

400

600

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Intermediært sengeafs 0633 HI

83 83

70

50

53

43

13

15

11 10

12

2


meropenem cefuroxim


benzylpenicillin vancomycin


pivmecillinam ampicillin

50

75

100

125

150

50

75

100

125

150

50

100

0

50

100

150

30

60

90

0

100

200

0

20

40

60

0

10

20

30

0

20

40

60

0

10

20

30

40

0

10

20

30

40

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Intermediært sengeafs 0633 HI

278

Kard-Endo senge afs. B1 FS

0%

1.1%

5.1%

1.5%

1.1%

6.7%

4.5%

80%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Kard−Endo senge afs. B1 FS, nov 2015 − apr 2016

80

6

4 2

0 3

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Kard−Endo senge afs. B1 FS

279

299

200

400

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Kard−Endo senge afs. B1 FS

67 50

30 24

22

15

14 13

0

15

10 4




pivampicillin ciprofloxacin


dicloxacillin clarithromycin

0

50

100

0

25

50

75

100

0

25

50

75

10

20

30

40

50

0

20

40

0

20

40

60

80

0

25

50

75

0

20

40

0

10

20

30

40

50

0

10

20

30

40

0

10

20

30

0

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Kard−Endo senge afs. B1 FS

280

Kard-Endo senge afs. B2 FS

0%

0.51%

2.9%

2.2%

0.82%

3.5%

4.4%

86%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Kard−Endo senge afs. B2 FS, nov 2015 − apr 2016

79

6

4 1

0 3

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Kard−Endo senge afs. B2 FS

281

398

200

400

600

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Kard−Endo senge afs. B2 FS

93

59

38 21

23 26

14 12

18 18

12 4





dicloxacillin ciprofloxacin

ampicillin clarithromycin

0

50

100

150

0

50

100

0

50

100

0

20

40

60

0

20

40

60

0

20

40

60

0

25

50

75

0

20

40

60

0

10

20

30

40

0

10

20

30

40

0

20

40

60

80

0

20

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Kard−Endo senge afs. B2 FS

282

Kardiologi amb afs 0841 HI

0%

0%

0%

0%

0%

0%

100%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Kardiologi amb afs 0841 HI, nov 2015 − apr 2016

0

100

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Kardiologi amb afs 0841 HI

283

2

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Kardiologi amb afs 0841 HI

2

0

0 0

0 0

0 0

0 0

0 0


doripenem cefepim





0

5

10

15

20

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Kardiologi amb afs 0841 HI

284

KardNefroEndo sengeafs 0641 HI

0%

2%

5.5%

0.11%

7.2%

5.1%

9.2%

71%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, KardNefroEndo sengeafs 0641 HI, nov 2015 − apr 2016

65

17

6 6

0 4

1 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, KardNefroEndo sengeafs 0641 HI

285

979

500

750

1000

1250

1500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, KardNefroEndo sengeafs 0641 HI

122

52

107

84

70 61

52 51

30 25

34

25

cefuroxim ampicillin






50

100

150

200

0

100

200

300

400

0

50

100

150

0

100

200

300

0

50

100

150

0

50

100

150

200

0

50

100

150

0

25

50

75

100

125

0

25

50

75

100

125

0

50

100

150

0

25

50

75

0

40

80

120

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, KardNefroEndo sengeafs 0641 HI

286

KardNefroEndo sengeafs 0842 HI

0%

0.45%

4.5%

0.32%

3.6%

5.8%

6.2%

79%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, KardNefroEndo sengeafs 0842 HI, nov 2015 − apr 2016

71

12

7 4

0 4

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, KardNefroEndo sengeafs 0842 HI

287

701

500

750

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, KardNefroEndo sengeafs 0842 HI

147

59

62 54

53 45

50

21

22 24

29 20





benzylpenicillin clarithromycin

pivampicillin meropenem

50

100

150

200

250

0

50

100

150

40

80

120

160

40

80

120

160

50

100

0

25

50

75

100

0

25

50

75

100

0

30

60

90

120

10

20

30

40

50

0

20

40

60

0

25

50

75

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, KardNefroEndo sengeafs 0842 HI

288

Kir sengeafs 0141 HI

0%

0.76%

2.7%

0%

26%

4.2%

5%

61%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Kir sengeafs 0141 HI, nov 2015 − apr 2016

52

8

3

31

0 0

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Kir sengeafs 0141 HI

289

330

200

300

400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Kir sengeafs 0141 HI

83 57

30

11

27

8

0 0

8

0

5

0





meropenem amoxicillin

vancomycin pivampicillin

30

60

90

120

20

40

60

80

100

0

25

50

75

100

0

50

100

0

20

40

60

0

20

40

60

0

10

20

30

40

0

20

40

60

0

10

20

30

0

10

20

30

40

50

0

5

10

15

20

0

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Kir sengeafs 0141 HI

290

Kir sengeafs B5 FS

0%

0.72%

3%

0.33%

9.9%

5.1%

9.2%

72%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Kir sengeafs B5 FS, nov 2015 − apr 2016

70

8

6 5

0 3

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Kir sengeafs B5 FS

291

322

0

250

500

750

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Kir sengeafs B5 FS

73 34

10 20

15 20

19 18

0

17

10

0



amoxicillin og enzym−inhibitor ampicillin




0

100

200

300

0

30

60

90

120

0

50

100

0

25

50

75

100

0

50

100

0

20

40

60

0

20

40

60

0

20

40

0

20

40

60

0

10

20

30

40

50

0

10

20

30

40

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Kir sengeafs B5 FS

292

Kir sengeafs B6 FS

0.4%

0.13%

15%

2.1%

7.6%

4.1%

9.1%

61%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Kir sengeafs B6 FS, nov 2015 − apr 2016

68

9

4 5

0 4

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Kir sengeafs B6 FS

293

350

0

200

400

600

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Kir sengeafs B6 FS

80 36

0 15

19 20

17 14

10 11

0

13



cefuroxim phenoxymethylpenicillin




0

50

100

150

200

0

25

50

75

100

0

100

200

300

0

25

50

75

100

125

0

20

40

60

0

25

50

75

100

0

20

40

0

20

40

60

0

20

40

60

80

0

10

20

30

40

50

0

10

20

30

40

50

0

10

20

30

40

50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Kir sengeafs B6 FS

294

Kir sengeafs K 0151 HI

0.37%

1.7%

6.5%

2.3%

26%

4.7%

5%

54%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Kir sengeafs K 0151 HI, nov 2015 − apr 2016

52

8

4

22

1 8

1 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Kir sengeafs K 0151 HI

295

449

300

400

500

600

700

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Kir sengeafs K 0151 HI

90 73

60

30

32

16

27 19

15

0

0 5



clarithromycin cefuroxim



pivampicillin vancomycin

0

50

100

150

200

50

75

100

50

100

0

50

100

150

0

25

50

75

100

0

40

80

120

0

20

40

60

0

20

40

60

0

20

40

60

0

20

40

60

0

10

20

30

40

0

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Kir sengeafs K 0151 HI

296

Kir sengeafs K 0161 HI

0.21%

3.2%

8.6%

0.13%

20%

4.8%

3.7%

59%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Kir sengeafs K 0161 HI, nov 2015 − apr 2016

57

7

3

22

0 5

2 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Kir sengeafs K 0161 HI

297

431

200

300

400

500

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Kir sengeafs K 0161 HI

90 83

69

15

27 22

10 10

9

0

0 2



pivmecillinam clarithromycin

ciprofloxacin amoxicillin

gentamicin phenoxymethylpenicillin

flucloxacillin meropenem

0

50

100

150

40

80

120

160

0

50

100

0

50

100

150

200

0

20

40

60

80

0

50

100

0

10

20

30

40

50

0

20

40

60

0

10

20

0

10

20

30

0

10

20

30

40

50

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Kir sengeafs K 0161 HI

298

Kir. endoskopiafs. FS

0%

0%

0%

0%

0%

0%

0%

100%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Kir. endoskopiafs. FS, nov 2015 − apr 2016

50 50

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Kir. endoskopiafs. FS

299

00.0

2.5

5.0

7.5

10.0

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Kir. endoskopiafs. FS

0 0

0

0

0 0

0 0

0 0

0 0

amoxicillin cefuroxim

ampicillin fosfomycin

doripenem cefepim




0.0

2.5

5.0

7.5

10.0

0

1

2

3

4

5

0.0

0.5

1.0

1.5

2.0

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Kir. endoskopiafs. FS

300

Lunge & inf.med. amb 0621 Lægegangen

1.8%

0%

14%

60%

3.7%

0%

0%

20%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Lunge & inf.med. amb 0621 Lægegangen, nov 2015 − apr 2016

0 0

0 0

80

8

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Lunge & inf.med. amb 0621 Lægegangen

301

74

0

100

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Lunge & inf.med. amb 0621 Lægegangen

50

0

9

0

0 0

0 0

0 0

0

0

sulfamethoxazol og trimethoprim sulfadiazin

clindamycin amoxicillin

vancomycin doxycyclin


phenoxymethylpenicillin moxifloxacin

ertapenem fosfomycin

0

50

100

150

0

50

100

150

0

10

20

30

40

50

0

25

50

75

100

0

5

10

15

0.0

2.5

5.0

7.5

10.0

0

5

10

15

0

5

10

15

0.0

2.5

5.0

7.5

10.0

0

2

4

6

0

1

2

3

4

5

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Lunge & inf.med. amb 0621 Lægegangen

302

Lungemed sengeafs 0655 HI

0%

0.15%

13%

0.028%

2.4%

6.9%

6.9%

71%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Lungemed sengeafs 0655 HI, nov 2015 − apr 2016

65

12

7 3

0 10

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Lungemed sengeafs 0655 HI

303

12281200

1600

2000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Lungemed sengeafs 0655 HI

245 210

115 107

89

97

79 60

45 47

30 28

amoxicillin amoxicillin og enzym−inhibitor




meropenem benzylpenicillin

metronidazol moxifloxacin

0

200

400

600

100

200

300

400

500

0

100

200

300

100

200

0

100

200

300

0

50

100

150

50

100

150

40

80

120

0

50

100

25

50

75

100

125

0

20

40

60

80

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Lungemed sengeafs 0655 HI

304

Lungemed. Sengeafd. B7 FS

0.57%

0.83%

14%

0.54%

2.5%

2.3%

8.7%

70%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Lungemed. Sengeafd. B7 FS, nov 2015 − apr 2016

63

11

7 3

0 9

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Lungemed. Sengeafd. B7 FS

305

704

600

1000

1400

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Lungemed. Sengeafd. B7 FS

116 96

46 58

80

56

49 46

10

25

15 12



pivmecillinam clarithromycin




0

100

200

300

400

0

100

200

0

50

100

150

0

50

100

150

200

0

50

100

150

200

0

100

200

300

0

50

100

0

25

50

75

100

0

200

400

0

25

50

75

0

20

40

60

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Lungemed. Sengeafd. B7 FS

306

Lungemed. Sengeafd. B8 FS

0.62%

0.33%

5.6%

1.2%

1.9%

2.7%

7.8%

80%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Lungemed. Sengeafd. B8 FS, nov 2015 − apr 2016

68

9

8 2

0 8

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Lungemed. Sengeafd. B8 FS

307

547

250

500

750

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Lungemed. Sengeafd. B8 FS

135 80

45 34

15

33

30 28

30

10

0 2



amoxicillin piperacillin og enzym−hæmmer




0

100

200

300

0

50

100

150

0

100

200

300

0

50

100

150

0

100

200

300

0

25

50

75

100

125

0

25

50

75

100

0

25

50

75

100

0

20

40

60

80

0

20

40

0

10

20

30

40

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Lungemed. Sengeafd. B8 FS

308

Nefrologisk amb-afs 0732 HI

0%

53%

0%

0%

6.8%

0%

0%

40%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Nefrologisk amb−afs 0732 HI, nov 2015 − apr 2016

0 0

0

33

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Nefrologisk amb−afs 0732 HI

309

12

0

25

50

75

100

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Nefrologisk amb−afs 0732 HI

0

2

0 0

0 0

0 0

0 0

0 0

flucloxacillin vancomycin

gentamicin ciprofloxacin

moxifloxacin tobramycin



cefepim minocyclin

0

25

50

75

100

0

3

6

9

0

5

10

15

0

5

10

15

20

0

10

20

0

5

10

0

5

10

0

1

2

3

4

5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Nefrologisk amb−afs 0732 HI

310

Nefrologisk HD-amb 0851 HI

0%

0%

0%

0%

3%

0%

6.1%

91%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Nefrologisk HD−amb 0851 HI, nov 2015 − apr 2016

72

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Nefrologisk HD−amb 0851 HI

311

30

0

50

100

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Nefrologisk HD−amb 0851 HI

24

0

0 0

0 0

0 0

0 0

0 0

flucloxacillin moxifloxacin




benzylpenicillin fusidinsyre

cloxacillin meropenem

0

10

20

30

40

50

0

10

20

30

0

25

50

75

0.0

2.5

5.0

7.5

10.0

0

10

20

30

0

2

4

6

8

0

5

10

15

0

1

2

3

4

5

0

2

4

6

0

5

10

0.0

2.5

5.0

7.5

10.0

0

1

2

3

4

5

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Nefrologisk HD−amb 0851 HI

312

Nefrologisk HD amb-afs 0921 HI

0%

0%

0%

0%

5.5%

0%

5.8%

89%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Nefrologisk HD amb−afs 0921 HI, nov 2015 − apr 2016

83

0

0 8

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Nefrologisk HD amb−afs 0921 HI

313

11

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Nefrologisk HD amb−afs 0921 HI

0 0

0 0

0 0

0 0

0 0

0 0


dicloxacillin amoxicillin og enzym−inhibitor

vancomycin ciprofloxacin

cefuroxim linezolid

clindamycin ampicillin

piperacillin og enzym−hæmmer fusidinsyre

0

5

10

15

20

25

0

10

20

30

0

5

10

15

20

0

10

20

30

0

1

2

3

4

5

0

5

10

15

0

1

2

3

4

5

0

5

10

15

0.0

2.5

5.0

7.5

10.0

0.0

2.5

5.0

7.5

10.0

0

1

2

3

0

2

4

6

8

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Nefrologisk HD amb−afs 0921 HI

314

Neurologisk afd 0671 HI

0.42%

0.69%

0.27%

2.1%

9.4%

4.9%

13%

69%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Neurologisk afd 0671 HI, nov 2015 − apr 2016

69

14

1 8

0 0

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Neurologisk afd 0671 HI

315

364

300

400

500

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Neurologisk afd 0671 HI

117 38

34 30

20 15

17

0

3 2

0 0



phenoxymethylpenicillin meropenem



nitrofurantoin trimethoprim

50

100

150

200

0

25

50

75

25

50

75

0

20

40

60

80

0

20

40

60

0

25

50

75

0

10

20

30

40

50

0

10

20

30

40

50

0

25

50

75

0

10

20

30

40

50

0

5

10

15

20

25

0

5

10

15

20

25

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Neurologisk afd 0671 HI

316

Neurologisk sengeafs 0871 HI

0%

0.79%

0.26%

2.1%

11%

1.6%

7.3%

77%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Neurologisk sengeafs 0871 HI, nov 2015 − apr 2016

69

16

2 11

0 1

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Neurologisk sengeafs 0871 HI

317

390

300

400

500

600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Neurologisk sengeafs 0871 HI

147

38

40 33

30

5

9 10

0 2

0 0





nitrofurantoin ampicillin

trimethoprim amoxicillin

50

100

150

200

0

40

80

120

0

25

50

75

0

20

40

60

0

20

40

60

0

20

40

60

0

10

20

30

40

0

10

20

30

40

0

5

10

15

20

25

0

10

20

30

40

0

10

20

30

40

50

0

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Neurologisk sengeafs 0871 HI

318

Neurorehab.sengeafs. A1 FS

0%

0%

0%

6.7%

13%

3.7%

1.3%

75%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Neurorehab.sengeafs. A1 FS, nov 2015 − apr 2016

73

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Neurorehab.sengeafs. A1 FS

319

66

0

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Neurorehab.sengeafs. A1 FS

17

0

0 0

0 0

0 0

0 0

0 0


amoxicillin og enzym−inhibitor trimethoprim


piperacillin og enzym−hæmmer vancomycin



0

20

40

60

80

0

5

10

15

20

0

10

20

30

0

5

10

15

20

25

0

5

10

15

20

25

0

10

20

30

0

5

10

15

0

5

10

15

0

5

10

15

0

10

20

30

0

5

10

15

20

0

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Neurorehab.sengeafs. A1 FS

320

Neurorehab.sengeafs. A3 FS

0%

0%

2.9%

7.2%

0%

16%

0%

74%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Neurorehab.sengeafs. A3 FS, nov 2015 − apr 2016

97

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Neurorehab.sengeafs. A3 FS

321

50

0

40

80

120

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Neurorehab.sengeafs. A3 FS

27

0

0 0

0 0

0 0

0 0

0 0



phenoxymethylpenicillin trimethoprim

ciprofloxacin moxifloxacin

sulfamethizol nitrofurantoin

cefalexin roxithromycin

0

25

50

75

0

10

20

30

40

50

0

10

20

30

0

10

20

30

0

5

10

15

20

0

5

10

15

20

25

0.0

2.5

5.0

7.5

10.0

0

5

10

15

20

0.0

2.5

5.0

7.5

10.0

12.5

0

5

10

15

20

25

0

1

2

3

4

5

0.0

2.5

5.0

7.5

10.0

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Neurorehab.sengeafs. A3 FS

322

Onkologisk amb E 0663 HI

100%

0%

0%

0%

0%

0%

0%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Onkologisk amb E 0663 HI, nov 2015 − apr 2016

0 0

0 0

0 0

0

100





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Onkologisk amb E 0663 HI

323

138

100

200

300

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Onkologisk amb E 0663 HI

112

0

0 0

0 0

0 0

0 0

0 0

tetracyclin doxycyclin

ceftriaxon meropenem


cefepim minocyclin



100

200

300

0

20

40

60

0

5

10

15

20

0.0

2.5

5.0

7.5

10.0

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Onkologisk amb E 0663 HI

324

Opvågnings afsnit 0132 HI

0%

0%

0%

0%

32%

0%

33%

35%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Opvågnings afsnit 0132 HI, nov 2015 − apr 2016

31 38

0

28

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Opvågnings afsnit 0132 HI

325

27

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Opvågnings afsnit 0132 HI

10 7

6

2

0 0

0 0

0 0

0 0



cloxacillin gentamicin


cefepim minocyclin


0

10

20

30

0

5

10

15

20

0

3

6

9

0.0

2.5

5.0

7.5

10.0

0.0

2.5

5.0

7.5

10.0

0

2

4

6

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Opvågnings afsnit 0132 HI

326

Ortkir amb-afs afs 0731 Hi

0%

0%

0%

0%

0%

0%

0%

100%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Ortkir amb−afs afs 0731 Hi, nov 2015 − apr 2016

100

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Ortkir amb−afs afs 0731 Hi

327

00

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Ortkir amb−afs afs 0731 Hi

0 0

0 0

0 0

0 0

0 0

0 0



cefepim minocyclin




0

5

10

15

20

25

0.0

2.5

5.0

7.5

10.0

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Ortkir amb−afs afs 0731 Hi

328

Ortkir sengeafs O 0152 HI

0%

0%

2.7%

0.98%

1.7%

2%

16%

77%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Ortkir sengeafs O 0152 HI, nov 2015 − apr 2016

76

17

3 2

0 1

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Ortkir sengeafs O 0152 HI

329

652

300

600

900

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Ortkir sengeafs O 0152 HI

113

100

98 82

59

53

13 15

10

0

1 0





piperacillin og enzym−hæmmer meropenem

clindamycin amoxicillin

0

50

100

150

200

0

100

200

300

0

100

200

0

50

100

150

200

250

0

50

100

150

0

25

50

75

0

20

40

60

0

20

40

60

0

10

20

30

0

20

40

60

0

20

40

60

0

10

20

30

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Ortkir sengeafs O 0152 HI

330

Ortkir sengeafs O 1551 HI

0%

0.17%

4.1%

1.2%

2.2%

1.7%

9.9%

81%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Ortkir sengeafs O 1551 HI, nov 2015 − apr 2016

73

14

4 2

0 3

0 0





0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

0%

25%

50%

75%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Ortkir sengeafs O 1551 HI

331

834

600

800

1000

1200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Ortkir sengeafs O 1551 HI

147 128

111 94

69 56

32 29

20 13

15 15





meropenem clindamycin

ampicillin amoxicillin og enzym−inhibitor

100

200

100

200

0

100

200

300

50

100

150

200

50

100

150

40

80

120

0

25

50

75

100

0

20

40

60

0

20

40

60

80

0

40

80

120

0

20

40

60

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Ortkir sengeafs O 1551 HI

332

Ortkir sengeafsnit 0661 HI

0%

0%

4.5%

0.86%

1.7%

2.8%

23%

67%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Ortkir sengeafsnit 0661 HI, nov 2015 − apr 2016

57

25

2 3

0 4

0 0





0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

0%

20%

40%

60%

80%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Ortkir sengeafsnit 0661 HI

333

477

200

400

600

800

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Ortkir sengeafsnit 0661 HI

116 75

53

39

45

17

13 0

10 0

0 0



phenoxymethylpenicillin clindamycin



amoxicillin linezolid

50

100

150

200

0

50

100

150

0

30

60

90

0

50

100

150

200

0

50

100

0

50

100

150

200

0

25

50

75

100

0

20

40

60

80

0

25

50

75

0

20

40

60

80

0

50

100

150

200

250

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Ortkir sengeafsnit 0661 HI

334

Palliativ sengafs A7A8 FS

12%

0%

0%

6.2%

0%

4.8%

13%

64%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Palliativ sengafs A7A8 FS, nov 2015 − apr 2016

71

8

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Palliativ sengafs A7A8 FS

335

74

50

100

150

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Palliativ sengafs A7A8 FS

13 0

0

6

0 0

0 0

0 0

0 0


flucloxacillin piperacillin og enzym−hæmmer



nitrofurantoin metronidazol

doxycyclin meropenem

0

20

40

60

80

0

20

40

60

0

20

40

60

0

5

10

15

20

0

10

20

30

40

50

0

10

20

30

0

5

10

15

20

0

5

10

15

20

0

5

10

15

20

25

0

5

10

15

0

5

10

15

20

0

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Palliativ sengafs A7A8 FS

336

SimNord indgang 51A, plan 2

0%

0%

0%

0%

0%

0%

38%

62%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, SimNord indgang 51A, plan 2, nov 2015 − apr 2016

10

63

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, SimNord indgang 51A, plan 2

337

00

20

40

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, SimNord indgang 51A, plan 2

0 0

0 0

0 0

0

0

0 0

0 0

cefuroxim ampicillin



clarithromycin fosfomycin

doripenem cefepim


0

5

10

15

20

0

10

20

30

0

5

10

15

0

5

10

15

0.0

2.5

5.0

7.5

10.0

0

2

4

0.0

0.5

1.0

1.5

2.0

2.5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, SimNord indgang 51A, plan 2

338

Øre-næse-hals amb C 0832 HI

0%

0%

0%

0%

0%

0%

74%

26%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Øre−næse−hals amb C 0832 HI, nov 2015 − apr 2016

100

0

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Øre−næse−hals amb C 0832 HI

339

00

5

10

15

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Øre−næse−hals amb C 0832 HI

0 0

0 0

0 0

0 0

0 0

0 0

flucloxacillin ertapenem


cefepim minocyclin




0

5

10

15

0

2

4

6

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Øre−næse−hals amb C 0832 HI

340

Øre-næse-hals OP afs C 0822 HI

0%

14%

0%

0%

0%

0%

86%

0%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Øre−næse−hals OP afs C 0822 HI, nov 2015 − apr 2016

0

100

0 0

0 0

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Øre−næse−hals OP afs C 0822 HI

341

5

0.0

2.5

5.0

7.5

10.0

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Øre−næse−hals OP afs C 0822 HI

5

0

0 0

0 0

0 0

0 0

0 0

cefuroxim gentamicin


dicloxacillin ampicillin


cefepim minocyclin


0.0

2.5

5.0

7.5

10.0

0

1

2

3

0

1

2

3

0

1

2

0.0

0.5

1.0

1.5

2.0

2.5

0.0

0.5

1.0

1.5

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

−0.50

−0.25

0.00

0.25

0.50

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Øre−næse−hals OP afs C 0822 HI

342

Øre-næse-hals sengeafs 0631 HI

1.6%

0.53%

4.8%

0.61%

5.3%

2.4%

8.1%

77%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler NO, Øre−næse−hals sengeafs 0631 HI, nov 2015 − apr 2016

65

16

4 5

0 4

0 0





0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

0%

25%

50%

75%

100%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, NO, Øre−næse−hals sengeafs 0631 HI

343

318

200

300

400

500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, NO, Øre−næse−hals sengeafs 0631 HI

61 54

38 22

19 15

10 13

0 0

5 0





flucloxacillin pivmecillinam

meropenem doxycyclin

20

40

60

80

100

25

50

75

100

0

25

50

75

100

0

20

40

60

80

10

20

30

40

0

10

20

30

40

0

20

40

60

0

10

20

30

40

50

0

10

20

30

40

50

0

20

40

0

10

20

30

0

5

10

15

20

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, NO, Øre−næse−hals sengeafs 0631 HI

344

Rigshospitalet og Glostrup Hospital

2.8%

2.2%

4.8%

16%

11%

13%

25%

25%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, nov 2015 − apr 2016

24 27

12 10

16

5

3 2





0%

10%

20%

30%

0%

10%

20%

30%

0%

10%

20%

30%

0%

10%

20%

30%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, Rigshospitalet og Glostrup Hospital

345

43791

35000

40000

45000

50000

55000

60000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH

6460 5750

5333 4828

2695 2372

1363 1116

1162 1018

1015 972

sulfamethoxazol og trimethoprim cefuroxim

meropenem ciprofloxacin




doxycyclin vancomycin

5000

6000

7000

8000

4000

5000

6000

7000

3000

4000

5000

6000

7000

8000

4000

5000

6000

7000

2000

2500

3000

3500

4000

1500

2000

2500

3000

3500

1000

1500

2000

2500

3000

1000

1500

2000

1000

1500

800

1000

1200

1400

1600

400

800

1200

1600

600

800

1000

1200

1400

1600

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH

346

-

0.96%

3.1%

3.9%

7.5%

12%

11%

27%

35%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, −, nov 2015 − apr 2016

32 29

10 11

8 4

3 1





0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, −

347

16486

12500

15000

17500

20000

22500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, −

2626

1597

1519 1427

795 750

825 700

505

208

398 407



amoxicillin og enzym−inhibitor sulfamethoxazol og trimethoprim


phenoxymethylpenicillin sulfadiazin

tobramycin piperacillin og enzym−hæmmer

2000

2500

3000

3500

800

1200

1600

2000

1000

1500

2000

800

1200

1600

2000

600

800

1000

1200

500

750

1000

1250

500

1000

1500

600

900

1200

1500

300

400

500

600

700

800

0

500

1000

1500

2000

250

500

750

1000

1250

400

600

800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, −

348

BørneUngeKlinikken

1%

8.2%

6.7%

15%

12%

9.4%

26%

22%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, BørneUngeKlinikken, nov 2015 − apr 2016

20

29

8 9

16

6

10

1





0%

10%

20%

30%

0%

10%

20%

30%

0%

10%

20%

30%

0%

10%

20%

30%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, BørneUngeKlinikken

349

2925

2000

2500

3000

3500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, BørneUngeKlinikken

617

452

276 181

201 137

105 83

84 60

71 56

meropenem sulfamethoxazol og trimethoprim

amoxicillin og enzym−inhibitor tobramycin

ciprofloxacin azithromycin

cefuroxim vancomycin

colistin amoxicillin

phenoxymethylpenicillin amikacin

300

400

500

600

700

800

400

600

800

1000

100

200

300

400

500

0

200

400

600

100

150

200

250

300

50

100

150

200

50

100

150

200

250

50

100

150

200

0

50

100

150

200

50

100

150

50

100

0

30

60

90

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, BørneUngeKlinikken

350

Hjerte-medicinsk Klinik B

0.3%

0.24%

2.3%

50%

5.7%

8.6%

17%

15%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Hjerte−medicinsk Klinik B, nov 2015 − apr 2016

17 17

9 6

46

2

1 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Hjerte−medicinsk Klinik B

351

4413

4000

5000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Hjerte−medicinsk Klinik B

2150 418

344 298

170 147

95

102

80

80

56 50

sulfamethoxazol og trimethoprim meropenem



moxifloxacin linezolid

amoxicillin azithromycin

dicloxacillin colistin

1000

1500

2000

2500

3000

200

400

600

100

200

300

400

500

600

200

300

400

500

0

100

200

300

400

500

0

100

200

300

50

100

150

200

250

50

100

150

200

0

100

200

300

400

40

80

120

160

50

100

150

200

250

0

50

100

150

200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Hjerte−medicinsk Klinik B

352

Hæmatologisk Klinik 1

0.46%

0.23%

5.4%

32%

6.3%

20%

9.2%

26%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Hæmatologisk Klinik 1, nov 2015 − apr 2016

25

9

20

5

35

5

0 0





0%

10%

20%

30%

40%

50%

0%

10%

20%

30%

40%

50%

0%

10%

20%

30%

40%

50%

0%

10%

20%

30%

40%

50%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Hæmatologisk Klinik 1

353

1949

1500

2000

2500

3000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Hæmatologisk Klinik 1

638 345

343 142

71

32

38 36

33 18

25 25

sulfamethoxazol og trimethoprim amoxicillin og enzym−inhibitor


piperacillin og enzym−hæmmer moxifloxacin

clarithromycin vancomycin

pivmecillinam clindamycin


250

500

750

1000

1250

200

400

600

200

300

400

500

50

100

150

200

250

50

100

0

50

100

150

200

0

50

100

150

0

50

100

150

0

50

100

0

25

50

75

100

125

0

50

100

150

0

25

50

75

100

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Hæmatologisk Klinik 1

354


0%

0.12%

13%

44%

4.9%

16%

7.4%

15%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%


15 10

15

5

41

12

0 0





0%

20%

40%

0%

20%

40%

0%

20%

40%

0%

20%

40%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned


355

3089

2500

3000

3500

4000

4500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD


1279 441

350 262

226 104

70 48

60

0

27 33

sulfamethoxazol og trimethoprim ciprofloxacin

azithromycin amoxicillin og enzym−inhibitor


vancomycin colistin

ceftazidim sulfadiazin

pivmecillinam moxifloxacin

1000

1500

200

400

600

200

400

600

100

200

300

400

500

100

200

300

400

500

0

50

100

150

200

50

100

0

50

100

150

0

50

100

0

100

200

300

0

30

60

90

0

25

50

75

100

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D


356


0.2%

1%

5.5%

9.4%

8.8%

29%

11%

36%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%


32

13

27

9

11 6

0 0





0%

20%

40%

0%

20%

40%

0%

20%

40%

0%

20%

40%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned


357

2055

1000

1500

2000

2500

3000

3500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD


562 499

225 240

88 53

69

60

51

11

8 0


sulfamethoxazol og trimethoprim meropenem

clindamycin colistin

piperacillin og enzym−hæmmer linezolid

vancomycin cefuroxim

fusidinsyre clarithromycin

400

600

800

200

400

600

800

100

200

300

400

500

0

200

400

600

50

100

150

200

0

50

100

150

200

0

25

50

75

100

0

50

100

150

0

50

100

0

50

100

150

0

20

40

60

0

30

60

90

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D


358

Intensiv Terapi Afsnit

0.43%

2.4%

7.2%

2.1%

24%

23%

34%

7.7%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Intensiv Terapi Afsnit, nov 2015 − apr 2016

6

41

21 22

2 6

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Intensiv Terapi Afsnit

359

1528

1000

1500

2000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Intensiv Terapi Afsnit

441

290

130 121

108 33

34

25

30 23

32 29



vancomycin colistin

clindamycin sulfamethoxazol og trimethoprim

erythromycin piperacillin og enzym−hæmmer

linezolid ampicillin

200

400

600

800

200

300

400

500

100

150

200

100

200

300

100

200

0

50

100

20

40

60

80

0

100

200

300

20

40

60

80

0

50

100

150

20

40

60

0

20

40

60

80

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Intensiv Terapi Afsnit

360

Kirurgisk Gastroenterologisk Klinik C

0.72%

0.073%

1.4%

8.4%

26%

13%

39%

11%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Kirurgisk Gastroenterologisk Klinik C, nov 2015 − apr 2016

10

41

14

24

7 2

0 0





0%

10%

20%

30%

40%

50%

0%

10%

20%

30%

40%

50%

0%

10%

20%

30%

40%

50%

0%

10%

20%

30%

40%

50%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Kirurgisk Gastroenterologisk Klinik C

361

1408

1200

1600

2000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Kirurgisk Gastroenterologisk Klinik C

262 220

230 200

100 80

60 30

32 24

29

17



sulfamethoxazol og trimethoprim ceftriaxon

linezolid phenoxymethylpenicillin

pivmecillinam vancomycin


100

200

300

400

500

160

200

240

280

320

100

200

300

400

100

200

300

400

500

50

100

150

200

0

50

100

150

40

80

120

0

25

50

75

100

0

25

50

75

100

125

0

50

100

0

20

40

60

0

25

50

75

100

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Kirurgisk Gastroenterologisk Klinik C

362

Nefrologisk Klinik

0.71%

0.12%

4.5%

29%

12%

12%

19%

23%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Nefrologisk Klinik, nov 2015 − apr 2016

24 19

11 10

31

4

0 0





0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

0%

10%

20%

30%

40%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Nefrologisk Klinik

363

1887

1000

1500

2000

2500

3000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Nefrologisk Klinik

600 192

180 148

148 75

63 60

60 55

30 32

sulfamethoxazol og trimethoprim ciprofloxacin



vancomycin amoxicillin og enzym−inhibitor

azithromycin linezolid

fusidinsyre phenoxymethylpenicillin

300

400

500

600

700

800

900

100

200

300

0

100

200

300

400

100

200

300

100

200

300

0

50

100

150

200

50

100

0

50

100

150

40

80

120

0

50

100

150

0

25

50

75

100

0

25

50

75

100

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Nefrologisk Klinik

364

Neuroanæstesiologisk Klinik

0.12%

0.4%

4.7%

0.061%

11%

17%

47%

20%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Neuroanæstesiologisk Klinik, nov 2015 − apr 2016

14

50

15 11

0 4

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Neuroanæstesiologisk Klinik

365

688

600

800

1000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Neuroanæstesiologisk Klinik

187

180

106 33

30

27

6 13

15

5

5 3

cefuroxim meropenem


erythromycin pivmecillinam

piperacillin og enzym−hæmmer ampicillin

vancomycin phenoxymethylpenicillin

linezolid fusidinsyre

100

150

200

250

0

100

200

300

400

50

100

150

0

20

40

60

10

20

30

40

50

60

0

25

50

75

100

0

20

40

60

0

30

60

90

0

10

20

30

40

0

20

40

60

0

20

40

0

10

20

30

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Neuroanæstesiologisk Klinik

366

Neurokirurgisk klinik

0.57%

0.63%

2.6%

0.14%

12%

13%

48%

23%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Neurokirurgisk klinik, nov 2015 − apr 2016

26

46

12 12

0 2

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Neurokirurgisk klinik

367

737

300

600

900

1200

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Neurokirurgisk klinik

180 135

74 67

25 22

20 17

0

13

6 0

cefuroxim meropenem


flucloxacillin linezolid

metronidazol fusidinsyre


ampicillin pivampicillin

100

200

300

0

100

200

300

50

100

150

200

250

0

50

100

150

200

0

50

100

150

0

20

40

60

0

25

50

75

100

0

25

50

75

0

25

50

75

10

20

30

40

0

20

40

60

80

0

30

60

90

120

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Neurokirurgisk klinik

368

Onkologisk klinik

40%

0.66%

3.3%

1.9%

3.2%

11%

9.5%

30%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Onkologisk klinik, nov 2015 − apr 2016

26

15

12

4

3 3

0

35





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Onkologisk klinik

369

2127

1000

2000

3000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Onkologisk klinik

715 264

225 158

160

74

56 79

50 50

33 24

doxycyclin ciprofloxacin

amoxicillin og enzym−inhibitor meropenem



azithromycin sulfamethoxazol og trimethoprim

metronidazol vancomycin

400

800

1200

100

200

300

400

500

100

200

300

400

100

200

300

400

100

200

300

100

200

300

50

100

150

200

0

50

100

150

200

0

25

50

75

100

0

40

80

120

0

25

50

75

100

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Onkologisk klinik

370

Ortopædkirurgisk klinik

0.32%

0.5%

3%

0%

14%

11%

48%

24%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Ortopædkirurgisk klinik, nov 2015 − apr 2016

23

50

9 14

0 3

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Ortopædkirurgisk klinik

371

1952

1000

1500

2000

2500

3000

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Ortopædkirurgisk klinik

691 215

159 150

80 68

68 53

68 36

28 30

cefuroxim meropenem


fusidinsyre vancomycin

linezolid pivmecillinam

phenoxymethylpenicillin clindamycin

moxifloxacin metronidazol

300

600

900

0

100

200

300

400

100

200

300

100

200

300

0

100

200

50

100

150

200

0

50

100

150

200

0

50

100

150

0

50

100

150

0

20

40

60

0

20

40

60

80

0

25

50

75

100

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Ortopædkirurgisk klinik

372

Thorax-kirurgisk Klinik RT

0.75%

0.78%

3.7%

0.43%

12%

13%

52%

18%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Thorax−kirurgisk Klinik RT, nov 2015 − apr 2016

20

53

11 11

0 2

0 0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Thorax−kirurgisk Klinik RT

373

1350

1000

1500

2000

2500

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Thorax−kirurgisk Klinik RT

414 276

138 75

50 35

40 37

31 20

18 18

cefuroxim meropenem


flucloxacillin linezolid

fusidinsyre pivmecillinam


vancomycin dicloxacillin

300

400

500

600

100

200

300

400

500

100

200

300

400

500

50

100

150

200

0

50

100

150

0

50

100

0

50

100

150

0

25

50

75

100

125

0

50

100

0

25

50

75

100

0

25

50

75

0

20

40

60

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Thorax−kirurgisk Klinik RT

374

Thoraxanæstesiologisk Klinik

0%

7.6%

5.6%

1.1%

9.5%

17%

54%

5.8%

tetracycliner




andre antibacterica




0% 25% 50% 75% 100%

Relativt forbrug af antibakterielle midler RH, Thoraxanæstesiologisk Klinik, nov 2015 − apr 2016

5

52

16 9

0 5

10

0





0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

0%

20%

40%

60%

2014−01 2014−07 2015−01 2015−07 2016−01 2016−072014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

Relativt forbrug af antibakterielle midler, RH, Thoraxanæstesiologisk Klinik

375

1420

1000

1200

1400

1600

1800

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

DSamlet forbrug af antibakterielle midler, RH, Thoraxanæstesiologisk Klinik

414 319

234 133

52 35

30 33

20

29

8 2

meropenem cefuroxim

ciprofloxacin gentamicin

vancomycin azithromycin

linezolid metronidazol

amoxicillin erythromycin

ampicillin sulfamethoxazol og trimethoprim

200

400

600

200

300

400

500

100

200

300

400

50

100

150

200

250

25

50

75

100

0

25

50

75

100

0

30

60

90

0

20

40

60

80

0

20

40

60

80

10

20

30

40

50

0

20

40

60

80

0

30

60

90

2014−01 2014−07 2015−01 2015−07 2016−01 2016−07 2014−01 2014−07 2015−01 2015−07 2016−01 2016−07

Måned

DD

D

Top−12−antibiotika, RH, Thoraxanæstesiologisk Klinik

376

Documents

Antibiotikaforbrugsmønstre på udvalgte hospitalsafdelinger ... · Antibiotikaforbrugsmønstre på udvalgte hospitalsafdelinger i Region Hovedstaden Task Force Forebyggelse af Hospitalsinfektioner